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ABSTRACT
THE MITOCHONDRIAL PROTEIN CARD19 REGULATES MEMBRANE INTEGRITY AND
TERMINAL LYSIS DOWNSTREAM OF CASPASE ACTIVATION AND GASDERMIN CLEAVAGE
Elisabet Bjanes
Igor Brodsky
During pyroptosis, inflammatory caspases cleave gasdermin D to release an N-terminal fragment
that generates plasma membrane pores, which in turn mediate cell lysis and IL-1 release.
However, certain stimuli or cell types release IL-1 cytokines in a gasdermin D-dependent manner
while remaining viable, a process termed hyperactivation. How these distinct cell fate choices are
regulated downstream of caspase activation is unknown. Here, we demonstrate that a
mitochondrial CARD-containing protein, CARD19, promotes the progression to terminal lysis
following initial pore formation downstream of caspase activation and gasdermin cleavage.
CARD19-deficient macrophages were protected from cell death, but had no discernable defects
in caspase activation, IL-1 secretion, or gasdermin cleavage. Differential expression of CARD19
was linked to differential cell death in populations of peritoneal macrophages. Mechanistically,
Card19-/- macrophages exhibited a subtle reduction in cleaved gasdermins present in light
membrane fractions. Our data also indiate that full-length gasdermin D and E partially localize in
close proximity to the cortical actin network and cell periphery in transfected cells. These
preliminary findings provide a potential alternative mechanism by which gasdermins are
regulated, in which full-length gasdermin D and E might be associated with the plasma
membrane and poised for pore formation. These results implicate CARD19 as a cellular factor
that positively regulates cell death by potentially promoting association of cleaved gasdermin
proteins with cellular membranes and provide insight into regulation of terminal steps of cell death
following caspase activation.
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CHAPTER 1: Introduction
1.1. Molecular mechanisms of cell death
Cell death is a highly conserved, essential mechanism by which the innate immune system
regulates countless cellular programs including development, tissue homeostasis, injury, and
disease. Cell death encompasses many highly dynamic and regulated pathways that can be
manipulated and modulated by the immune system, pathogens, and therapeutic agents. Early
investigations largely classified cell death based on morphological characteristics such as the
rounding, shrinking, and blebbing of cells during apoptosis or swelling and rupture of membranes
during necrosis. Molecular mechanisms are now used as a typical means of classification with an
emphasis on the genetic requirement of death mediators. Over a dozen regulated cell death
(RCD) pathways have been recognized, some with broad functions across cell types while others
are restricted to specific cell types and triggers. Perhaps the best characterized of these
pathways include apoptosis, pyroptosis, and programmed necrosis, also known as necroptosis.
Despite significant advances in our understanding of regulatory mechanisms governing these
pathways, many key mediators remain to unidentified. In our quest to understand how the innate
immune system regulates cell death, we identified CARD19 (also known as BinCARD or Bcl-10
interacting protein with CARD) as a novel mediator of RCD. The central objective of this thesis
is to characterize the role of CARD19 during RCD and identify the mechanism by which it
mediates cell death.
In chapter one, the current understanding of molecular mechanisms governing apoptosis,
pyroptosis, and programmed necrosis will be discussed. In chapter two, the in vitro and in vivo
contributions of CARD19 to RCD will be characterized. We will show that CARD19 is required for
maximal induction of the caspase-dependent apoptotic and pyroptotic pathways independent of
cytokine production. In chapter three, we identify the pyroptotic executioner gasdermin D as a
contributor to apoptosis in a caspase-8 dependent manner. Finally, in chapter four we will
explore the mechanisms of CARD19 activity. We will show that CARD19 mediates the
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association of cleaved gasdermin family members with the plasma membrane and may interact
with gasdermin D at mitochondria and plasma membrane interfaces.
1.1.1.

Developmental and homeostatic apoptosis

Classically, apoptosis is characterized by the organized disassembly of a cell following
developmental or homeostatic signals (Kerr et al., 1972). Apoptosis is separated into two
categories based on the location of the initiating stimuli. The intrinsic apoptosis pathway is
induced in response to intracellular signals while the extrinsic apoptosis pathways is initiated by
extracellular signals. Bcl-2 family members tightly regulate activation of the intrinsic pathway. Prosurvival members Bcl-2, Bcl-xL, Mcl-1, A1 and Bcl-W selectively sequester and inhibit proapoptotic Bcl-2 members during homeostasis (Chen et al., 2005; Letai et al., 2002; Llambi et al.,
2011; Willis et al., 2005). Stimuli such as growth factor or cytokine deprivation, DNA damage,
unfolded protein accumulation, and ER stress activate the pro-apoptotic Bcl-2 sensors Noxa, Bik,
Bad, Bid, Bim, Puma, Hrk, and Bmf (Li et al., 1998; Nakano and Vousden, 2001; Oda et al., 2000;
Puthalakath et al., 1999; Zha et al., 1996). These sensitizers displace inhibitory pro-survival Bcl-2
members bound to pro-apoptotic members and induce conformational changes in Bax and Bak,
Bcl-2 pore forming proteins (Figure 1.1). Conformational change promotes relocation of cytosolic
Bax to the outer mitochondrial membrane (OMM) and insertion of mitochondria-localized Bak
helices into the OMM (Annis et al., 2005; Kim et al., 2009; Oh et al., 2010; Yethon et al., 2003).
Bax and Bak oligomerize into pores that facilitate catastrophic mitochondrial outer membrane
permeabilization (MOMP) and cytochrome c release (Bleicken et al., 2013; Jürgensmeier et al.,
1998; Subburaj et al., 2015; Wei et al., 2000). Cytochrome c binds to the adaptor Apaf-1 and the
cysteine protease caspase-9, inducing formation of the apoptosome (Li et al., 1997; Liu et al.,
1996; Zou et al., 1999), a supramolecular activation platform for the executioner caspases-3, -6,
and -7 (Li et al., 1997; Slee et al., 1999; Srinivasula et al., 1998; Yang et al., 1998). Upon
activation by the apoptosome, executioner caspases cleave numerous cellular substrates
including PARP, ROCK I, RhoGDI, co-chaperone p23, gelsolin, and lamin A, leading to the
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organized dismantling of the cell into small vesicles termed apoptotic bodies that are
phagocytosed with little inflammation or bystander damage (Slee et al., 2001). Notably, caspase3 cleaves the inhibitor of CAD endonuclease (ICAD), licensing CAD to degrade nuclear DNA and
cause DNA laddering characteristic of apoptosis (Figure 1.1) (Sakahira et al., 1998).
Extrinsic apoptosis is induced when extracellular death ligands like Fas ligand, TRAIL, and
TNF bind their cognate death receptors Fas, Death Receptor 4 and 5, and TNF receptor,
respectively, which initiates receptor trimerization (Figure 1.1) (Gruss and Dower, 1995; Itoh et
al., 1991; Oehm et al., 1992). Receptor trimerization promotes recruitment of the adaptor protein
FADD to all three receptors (Hsu et al., 1996b; Hsu et al., 1995; Kischkel et al., 1995; Kuang et
al., 2000; Muzio et al., 1996), while TNFR additionally recruits the adaptor, TRADD, and receptor
interacting protein kinase 1 (RIPK1 or RIP1) (Hsu et al., 1996a; Hsu et al., 1995). FADD recruits
pro-caspase-8, forming the death inducing signaling complex (DISC) (Kischkel et al., 1995). Procaspase-8 dimerization initiates auto-proteolysis and activation (Oberst et al., 2010). Cleaved,
dimerized caspase-8 is released into the cytosol where it cleaves caspase-3 (Stennicke et al.,
1998). Caspase-8 also cleaves Bid, inducing the mitochondrial arm of the intrinsic apoptosis
pathway (Li et al., 1998). Under homeostatic conditions, premature caspase-8 activation is
inhibited by heterodimerization of caspase-8 with a catalytically inactive homolog, c-FLIP (Figure
1.1) (Kataoka et al., 1998; Scaffidi et al., 1999).
1.1.2.

Inflammatory apoptosis

While apoptosis has traditionally been categorized as an immunoquiescent form of
programmed cell death, recent evidence has expanded our understanding that apoptosis
encompasses more than just homeostatic or developmental events. During Yersinia
pseudotuberculosis infection, cells that escape Yersinia effector blockade produce low levels of
TNF that mediates TRIF-independent apoptosis that is protective during in vivo infection
(Peterson et al., 2017). Furthermore, Mycobacterium tuberculosis infection of macrophages and
monocytes stimulates potent TNF-α responses by apoptotic cells (Ciaramella et al., 2002).
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Infection of mast cells with several influenza virus subtypes induces release of pro-inflammatory
cytokines concomitant with apoptosis (Liu et al., 2014). Immunogenic apoptosis is not strictly
limited to infection and has been reported in the context of cancer and sterile initiators of
apoptosis. Treatment of cancer cells with some anti-tumor agents such as anthracyclines and γirradiation induced immunogenic apoptosis (Casares et al., 2005; Obeid et al., 2007). HMGB1, a
chromatin remodeling protein that regulates transcription factor access to DNA, is released from
T cells in response to chemical inducers of apoptosis such as staurosporine, cycloheximide, and
etoposide in a caspase-dependent manner (Bell et al., 2006). Upon release from cells, HMGB1
acts as an alarmin by signaling through TLR2, TLR4, and the receptor for advanced glycation
products (RAGE) to attract and activate immune cells to the site of injury or infection (Andersson
et al., 2000; Park et al., 2006; Schiraldi et al., 2012; Yu et al., 2006). Together, these examples
highlight a few instances in which apoptosis is accompanied by pro-inflammatory cytokines and
danger molecules.
1.1.3.

Pyroptosis

Pyroptosis is a highly inflammatory process accompanied by lysis and release of cellular
contents, including pro-inflammatory IL-1 family cytokines (Martinon et al., 2002). Detection of
extracellular microbial products like lipopolysaccharide (LPS), foreign nucleic acids, and
breakdown products of cells by germline-encoded pattern recognition receptors (PRRs) induces
upregulation of pro-IL-1 family cytokines via NFκB signaling (Bauernfeind et al., 2009; Ghonime
et al., 2014; Perera and Waldmann, 1998). Initiation of pyroptosis is mediated by Nod-like
receptors (NLRs), a family of tripartite intracellular PRRs that detect intracellular microbial
products in animals and plants (Jones et al., 2016). The N-terminal region of NLRs contains a
protein-protein interaction domain such as a caspase-activation and recruitment domain (CARD),
Pyrin domain, or baculovirus inhibitor repeat (BIR) domain which mediates homotypic protein
interactions between NLRs, caspases, and the bipartite adaptor ASC (also known as PyCARD).
A centralized NOD or NACHT (nucleotide-binding domain) mediates dNTPase activity and
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oligomerization (Leipe et al., 2004). The C-terminal leucine rich region (LRR) is often involved in
sensing the activating stimuli and maintains NLRs in inactive conformations prior to activation.
Mutations in or loss of the C-terminal region can render some NLRs constitutively active
(Bendahmane et al., 2002; Tanabe et al., 2004). Upon recognition of intracellular microbial
products, NLR sentinels recruit ASC, if necessary, oligomerize and assemble into an
inflammasome with pro-caspase-1 (Oroz et al., 2016; Stehlik et al., 2003). These massive
complexes can be visualized as bright puncta by confocal microscopy and are termed ASCspecks due to the colocalization of ASC, caspase-1, and IL-1β. Caspase-1 undergoes autoproteolysis and activation, allowing it to cleave IL-1 family members (Martinon et al., 2002) and
the pore-forming protein gasdermin D (Kayagaki et al., 2015; Shi et al., 2015a). Following
cleavage, the N-terminus of gasdermin D oligomerizes, inserts into the plasma membrane, and
facilitates release of mature IL-1 and cell lysis (Chen et al., 2016; Ding et al., 2016; Liu et al.,
2016).
Presence of multiple NLRs in immune and barrier cells confers broad protection against
diverse microbial products and indicators of stress while maintaining ligand specificity (Figure
1.2). For example, the NLRP1b inflammasome is activated in response to direct cleavage of the
N-terminus of NLRP1b by anthrax lethal factor and by ubiquitylation dependent activity of the
Shigella flexneri E3 ligase IpaH7.8 (Bachovchin et al., 2018; Sandstrom et al., 2018). Cleavage of
the N-terminus induces proteasomal degradation, allowing the C-terminus of NLRP1b to activate
caspase-1. Numerous microbial products are detected by the NLRP3 inflammasome including
extracellular ATP (Pelegrin and Surprenant, 2007), pore forming toxins (Craven et al., 2009;
Mariathasan et al., 2006; McNeela et al., 2010; Melehani et al., 2015; Perregaux and Gabel,
1994; Toma et al., 2010), potassium efflux (Katsnelson et al., 2015; Muñoz-Planillo et al., 2013),
reactive oxygen species (ROS) (Cruz et al., 2007; Menu et al., 2012), lysosomal damage (Halle
et al., 2008; Hornung et al., 2008), uric acid (Martinon et al., 2006) and other crystals (Dostert et
al., 2008; Hornung et al., 2008). Potassium efflux inducing stimuli trigger disassembly of the
trans-Golgi network into dispersed structures (dTGN). Phosphatidylinositol 4-phosphate (PtdIns4)
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on dTGN binds to the polybasic region of NLRP3, forming a scaffold for NLRP3 and ASC
aggregation and inflammasome formation (Chen and Chen, 2018). Additionally, NLRP3 and
caspase-1 are recruited to mitochondrial membranes in response to mitochondrial ROS
production and form inflammasomes following calcium flux (Elliott et al., 2018).
The Naip family of sensors serve as additional sentinels for NLRC4 inflammasome activation
(Figure 1.2). Multiple murine Naips specifically detect bacterial flagellin and components of
needle-like apparatuses known as an injectosome or a secretion system, which are used by
bacteria to inject effectors into target cells (Kofoed and Vance, 2011). In contrast, a single
functional NAIP recognizes these microbial ligands in human cells (Yang et al., 2013). Following
sensing by Naips or NAIP, NLRC4 oligomerizes and activates caspase-1 in ASC-dependent and independent processes (Franchi et al., 2006; Li et al., 2018; Mariathasan et al., 2004; Miao et al.,
2006; Poyet et al., 2001). NLRP6 is a microbiome sentinel of the intestinal epithelium where it is
activated by taurine, a microbiota-regulated metabolite. NLRP6 subsequently activates caspase1, inducing IL-18 release and stimulating AMP production in an NFκB-dependent manner (Levy et
al., 2015). As of yet unidentified microbial products or effector activities by Yersinia pestis, the
causative agent of plague, activate the NLRP12 inflammasome (Vladimer et al., 2012).
Two additional microbial sensors are structurally and evolutionarily unrelated to the NLR
family, AIM2 and Pyrin (Figure 1.2). AIM2, a member of the PYHIN family, binds cytosolic
double-stranded DNA from a variety of sources including vaccinia virus, murine CMV, Francisella,
and L. monocytogenes with its HIN-200 domain (Rathinam et al., 2010). After association with
dsDNA, AIM2 binds ASC and caspase-1 to form an inflammasome. Pyrin detects inactivation or
modification of cellular RhoA GTPases (Heilig and Broz, 2018; Pawlowski et al., 2001; Xu et al.,
2014). RhoA GTPases phosphorylate kinases PKN1 and 2 which phosphorylate 14-3-3ε.
Phospho-14-3-3ε binds, phosphorylates and inactivates pyrin during homeostatic conditions.
Multiple bacterial effectors from a variety of species including Vibrio parahaemolyticus,
Clostridium difficile, C. botulinum, Burkholderia cenocepacia, Y. pestis, and Y. psueotuberculosis
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inhibit or modify RhoA GTPases, ultimately leading to dephosphorylation and activation of the
pyrin inflammasome (Chae et al., 2006; Xu et al., 2014).
Pyroptosis can also be induced by pro-inflammatory caspase-11 (Figure 1.2). In this noncanonical pathway, LPS binds directly to caspase-11, promoting dimerization, auto-proteolysis
and activation (Ross et al., 2018; Shi et al., 2014). Active caspase-11 cleaves gasdermin-D which
undergoes oligomerization and pore formation (Kayagaki et al., 2015). As a consequence of pore
formation, potassium efflux triggers canonical pyroptosis via the NLRP3/ASC/Caspase-1
inflammasome and release IL-1 (Rühl and Broz, 2015). The human homologs, caspase-4 and -5,
act in a similar manner in human cells (Shi et al., 2014). Initial reports describing caspase-1-/mice used 129 embryonic stem cells (Kuida et al., 1995; Li et al., 1995), which were found to
carry an inactivating passenger mutation at the caspase-11 gene locus (Kayagaki et al., 2011).
Caspase-11 is adjacent to caspase-1 and likely arose by gene duplication. The gene proximity
precluded elimination of the passenger mutation despite multiple generations of backcrossing.
After the passenger mutation was identified, replication of the original findings revealed distinct
yet complimentary roles for caspase-1 and -11 (Kayagaki et al., 2011; Man et al., 2017a; Man et
al., 2017b).
While pyroptosis is generally characterized by the release of IL-1 family cytokines, evidence
suggests the two events can be decoupled. IL-1 cytokine release and pyroptotic cell lysis are
spatially and temporally linked but regulated separately. For example, cells deficient for IL-1 are
still competent for pyroptotic cell death (Le Feuvre et al., 2002; Monack et al., 2001).
Furthermore, treatment of pyroptotic cells with the osmoprotectant glycine rescues cell lysis but
does not prevent IL-1 release or pore formation as measured by ethidium bromide uptake
(Brennan and Cookson, 2000; Fink and Cookson, 2006). More recently, several reports have
identified settings in which cells have activated effector caspases and released IL-1 without
undergoing lysis, a state termed hyperactivation. For example, human monocytes release IL-1 in
a caspase-8 dependent manner after detection of LPS by TLR4 (Gaidt et al., 2016; Gaidt and
Hornung, 2017). Dendritic cells recognize oxidized lipids from macrophage cellular debris and

7

release IL-1 (Zanoni et al., 2016; Zanoni et al., 2017). Peritoneal neutrophils release sustained
bursts of IL-1 in response to debris from infected macrophages (Chen et al., 2014). Murine
macrophages release IL-1 in response to breakdown products from S. aureus peptidoglycan in a
process that genetically requires gasdermin-D (Evavold et al., 2018). These examples illustrate
an outstanding question in the cell death field. Is hyperactivation a separate event from pyroptosis
with a checkpoint regulating life and death? Or, is hyperactivation a precursor to eventual
pyroptosis once the activation stimulus crosses a certain threshold? While these questions have
not been conclusively answered, we will provide some illumination on this topic in Section 2.2.7.
1.1.4.

Programmed necrosis

Although necrosis is often described in the context of sudden injury or stress, programmed
necrosis or necroptosis, is a highly regulated process (Figure 1.3). In contrast to apoptosis and
pyroptosis, programmed necrosis is caspase-independent and commonly initiated when apoptotic
caspases are inhibited in the presence of activating stimuli such as TNF and LPS (Ma et al.,
2005). When TNF induces receptor trimerization of TNFR, FADD, RIPK1, cellular inhibitor of
apoptosis 1 and 2 (cIAP1/2), and TNFR-associated factor 2 and 5 (TRAF2/5) are also recruited
into a pro-survival complex (Csomos et al., 2009; Micheau and Tschopp, 2003; Rothe et al.,
1995). In the absence of secondary signals, cIAP1/2 polyubiquitylate K63 chains onto RIPK1
(Bertrand et al., 2008), forming a docking site for transforming growth factor-β-activated kinase 1
(TAK1). TAK1 recruits TAK1 binding protein 2 and 3 (TAB2/3), initiating canonical NFκB signaling
to promote upregulation of pro-survival genes (Kanayama et al., 2004). Following TNFR receptor
internalization, RIPK1 is deubiquitylated by CYLD and recruited to a cytoplasmic complex with
caspase-8, FADD, TRADD, and RIPK3 (Feoktistova et al., 2011; Tenev et al., 2011; Wang et al.,
2008). Caspase-8 cleaves RIPK1 and RIPK3, promoting apoptosis and inhibiting programmed
necrosis. However, when caspase-8 is inhibited by synthetic chemicals or by microbial effectors,
RIPK1 and RIPK3 form β-amyloid filaments in a process dependent on multiple phosphorylation
events (Cho et al., 2009; He et al., 2009; Li et al., 2012; Mompeán et al., 2018). This complex,
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known as the necrosome, recruits and phosphorylates the pseudokinase MLKL, which
oligomerizes and forms a lytic pore at the plasma membrane (Dondelinger et al., 2014; Newton et
al., 2014; Sun et al., 2012; Zhao et al., 2012).
1.1.5.

Cell death crosstalk

Investigation of RCD pathways is often conducted in a reductionist manner with cell death
assays conducted following the ablation or inhibition of a specific gene or mediator. However, this
method of experimentation often fails to account for the dynamic interactions within and between
cell death pathways and provides an overly simplistic view of RCD (Figure 1.4). An excellent
example of this comes from early attempts to generate caspase-8 null mice, which are embryonic
lethal due to necrosis in developing circulatory tissue. Caspase-8 null mice were successfully
generated on a Ripk3-/- mouse background by Oberst and colleagues, identifying a role for
caspase-8 in regulating necrosis in addition to its apoptotic function (Oberst et al., 2011). Indeed,
caspase-8 homodimers and heterodimers with its catalytically inactive homolog, c-FLIP,
constitutively repress programmed necrosis by preventing formation of the necrosome (Figure
1.3). Additionally, Bachovchin and colleagues found that recombinant caspase-3 and -7 cleaved
human gasdermin-D at a non-conserved site to generate an inactive gasdermin-D fragment and
prevent pyroptosis (Taabazuing et al., 2017). Conversely, while caspase-8 is recruited to ASCspecks containing caspase-1 and ASC after nigericin treatment, cleaved caspase-8 is not
detectable, suggesting that active inflammasomes may inhibit apoptotic activation (Schneider et
al., 2017).
In addition to examples of cross-pathway inhibition, RCD pathways overlap sufficiently that
chemical or microbial inhibition of one can induce activation of another. For example, in human
macrophages and monocytes, inhibition or genetic ablation of gasdermin D in the presence of
chemical inducers of pyroptosis results in apoptotic morphology and the cleavage of apoptotic
effector caspases-3, and -7 (Taabazuing et al., 2017). This cleavage is attributed to caspase-1
since the purified enzyme is capable of cleaving both caspases-3 and -7 in vitro (Van de Craen et

9

al., 1999). Additionally, the putative activation of caspase-7 by caspase-1 contributes to control of
Legionella pneumophila replication infection in vivo (Akhter et al., 2009). Furthermore, caspase-8
compensates for loss of caspase-1 by mediating IL-1β cleavage in an NLRP3 and ASCdependent manner in bone marrow dendritic cells (BMDCs) following TLR2 stimulation
(Antonopoulos et al., 2015). In bone marrow derived macrophages (BMDMs), caspase-8 cleaves
IL-1β after treatment with poly[I:C] and LPS subsequent to TLR3 and TLR4 stimulation (Maelfait
et al., 2008). Caspase-8 forms an inflammasome with Naip5, NLRC4, and ASC in response to
Legionella pneumophila flagellin when caspase-1 or gasdermin D are inhibited (Mascarenhas et
al., 2017). Additionally, cytosolic DNA delivered by electroporation or released during Francisella
tularensis infection activates caspase-8 via the AIM2/ASC inflammasome in the absence of
caspase-1 (Pierini et al., 2012; Sagulenko et al., 2013). While Ripk3Casp8-/- macrophages have a
defect in IL-1β production in response to pyroptotic stimuli, this may be in part due to a defect in
caspase-8 dependent upregulation of Nlrp3 and Il1b genes during the priming phase of
pyroptosis (Gurung et al., 2014).
Cross-pathway activation can also occur in the absence of inhibition. During Y.
pseudotuberculosis infection, caspase-8, FADD, and RIPK1 mediate caspase-1 cleavage
independent from inflammasome components (Philip et al., 2014) and caspase-8 is recruited to
an NLRC4/ASC inflammasome during S. Typhimurium infection (Man et al., 2013). Although
genetic models and disease associated mutations in cell death genes in humans clearly
demonstrate that these pathways are not truly redundant, these examples highlight the ways in
which the innate immune system has evolved alternative activation mechanisms to combat
genetic or pathogenic loss of RCD function.
1.1.6.

Molecular cell death scaffolds

Formation of the supramolecular signaling and death complexes described in previous
sections depends upon homotypic protein interactions of the evolutionarily conserved death
domain superfamily. Although members have little primary sequence homology, proteins in this
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family share a similar secondary and tertiary structure known as a death fold, a six alpha-helical
bundle that mediates protein:protein interactions (Chou et al., 1998; Eberstadt et al., 1998; Hiller
et al., 2003; Huang et al., 1996). The death domain superfamily is further divided into four
subfamilies: the death domain (DD), death effector domain (DED), pyrin domain (PYD), and
caspase activation and recruitment domain (CARD) families (Park et al., 2007; Reed et al., 2004).
With few exceptions, interactions between family members are almost exclusively homotypic, i.e.
DED interacts with other DEDs (Nam et al., 2004). Homotypic interactions facilitate the activation
of family members through dimerization and higher-order oligomerization, auto-proteolysis, and
trans-phosphorylation, facilitating the formation of signaling complexes such as the apoptosome,
inflammasomes, and necrosome (Park et al., 2007).
Two notable members of the superfamily include the apoptotic and pyroptotic initiators
caspase-8 and caspase-1, which contain two DEDs and a CARD, respectively. Section 1.1.5.
highlights several examples where caspase-8 and caspase-1 cross-activate pyroptosis and
apoptosis, respectively, suggesting a possible interaction between the two caspases. We
hypothesized that the Bcl-10, CARMA1, MALT1 complex might bridge caspase-8 and caspase-1.
Bcl-10, CARMA1, and caspase-1 contain CARDs while MALT1 and caspase-8 have a DD and
DEDs, respectively. Brian Schaefer, a collaborator at the Uniformed Services University,
generated Carma1-/- mice to test whether it might be involved in Yersinia-induced caspase-8 and
-1 dependent RCD. As a control, he also generated a mouse deficient for another member of the
death domain superfamily, CARD19, which was predicted to be uninvolved in RCD.
Unexpectedly, CARMA1 proved to be unimportant for Yersinia-induced apoptosis, while Card19-/macrophages had a striking defect in cell death in response to Yersinia.
CARD19 belongs to the CARD subfamily of the death domain superfamily and contains an Nterminal CARD and a C-terminal transmembrane domain (Chen et al., 2013). CARD19 is highly
conserved in mammals and expressed ubiquitously across tissues with highest expression seen
in immune cells (Chen et al., 2013; Woo et al., 2004). Humans carry a second non-coding
CARD19 isoform that is not evolutionarily conserved or present in other mammals. When
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artificially overexpressed in Jurkat T cells, this isoform was shown to suppress T cell receptor
induced Bcl-10 phosphorylation and subsequent NFκB activation and termed BinCARD, or Bcl-10
interacting protein with CARD (Woo et al., 2004). This activity has not demonstrated under
endogenous conditions in primary cells. Since this isoform is not conserved, present in rodents,
or protein-coding under endogenous conditions, we will refer to the dominant isoform (in humans)
and only isoform in mice as CARD19. When ectopically expressed in HEK293T cells, CARD19
overlapped with markers from the ER and mitochondria (Chen et al., 2013). The CARD of
CARD19 was crystalized by Chen and colleagues which revealed that the three cysteines in the
CARD were oxidized and that two likely form a disulfide bond (Chen et al., 2013). CARDs interact
through primarily electrostatic and charged residues; therefore, it is difficult to reliably predict
binding partners based on structure or amino acid sequence. A role for CARD19 in innate
immunity and RCD in response to bacterial infection has not been reported.
While the cell death field has made incredible progress in understanding the mechanisms
and pathways that govern the ways in which cells die in response to various stimuli, much
remains to be elucidated. The initial caspase responses and signaling cascades activated by
death-inducing stimuli are well known, but much less is understood about the regulation of
terminal events that occur just prior to cell lysis. The importance of the gasdermin family as
mediators of cell lysis is a relatively new finding for the RCD field and provokes additional
questions regarding the regulation and modulation of gasdermin pore formation. The aim of this
thesis is to characterize the function of CARD19 in cell death and our findings provide insight into
the regulatory mechanisms of terminal events in cell death.

1.2. In vivo models of regulated cell death
The RCD pathways discussed in previous sections play essential roles in the innate immune
system response to in vivo infection. In this section, we will discuss two bacterial pathogens,
Yersinia pseudotuberculosis and Salmonella Typhimurium, that both induce apoptosis and
pyroptosis, and the mechanisms by which RCD contributes to antimicrobial defenses.
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1.2.1.

Yersinia pseudotuberculosis

Yersinia pseudotuberculosis is a Gram-negative, coccobacillus in the Enterobacteriaceae
family. It is one of three pathogens in the Yersinia genus along with the closely related Y.
enterocolitica and Y. pestis, the causative agent of bubonic and pneumonic plague (Perry and
Fetherston, 1997). Y. pestis diverged from Y. pseudotuberculosis following the acquisition of two
virulence plasmids that conferred the ability to replicate in the lungs and cause invasive disease
(Lathem et al., 2007; Zimbler et al., 2015). Like Y. enterocolitica, Y. pseudotuberculosis (Yp) is a
natural human and rodent enteric pathogen that typically causes self-limiting gastroenteritis in
humans following ingestion of contaminated food or water. In the murine model of oral infection,
Yp causes localized infection of the mesenteric lymph nodes and Peyer’s patches after crossing
the intestinal epithelium via M cells as well as systemic infection of distal sites such as the spleen,
liver, and lung (Figure 1.5) (Barnes et al., 2006; Clark et al., 1998; Grützkau et al., 1990). A
hallmark of Yp infection is the formation of granuloma-like structures in lymph tissue, hence the
designation “pseudotuberculosis” (Mair and El-Maraghi, 1979). Systemic Yp infection in mice
mimics severe disease in humans caused by Yersinia pestis.
Yp injects virulence factors known as Yops into cells with a type three secretion system
(T3SS) needlelike apparatus (Cornelis, 2006; Cornelis and Wolf-Watz, 1997; Hoiczyk and Blobel,
2001; Michiels et al., 1990; Rosqvist et al., 1994). Yp infection initially induces expression of prosurvival genes including the inhibitors of apoptosis (IAPs) and cFLIP. However, the Yp effector
protein YopJ is injected into cells where it acetylates the activation loops of MEK2 and IKK,
potently inhibiting the MAPK and NFκB signaling pathways, respectively (Mukherjee et al., 2006;
Orth et al., 1999; Palmer et al., 1998; Schesser et al., 1998), suppressing the expression of antiapoptotic genes (Zhang et al., 2005). Loss of cFLIP allows recruitment of caspase-8 to the DISC,
resulting in caspase-8 dimerization and auto-proteolysis that initiates the apoptotic cascade. In
activated macrophages, caspase-8, RIPK1, and FADD mediate caspase-1 dependent pyroptosis
independent of other inflammasome components (Philip et al., 2014). Murine models of Yp
infection reveal the biological significance of Yersinia-induced death. Ripk3Casp8-/- mice succumb
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to oral infection within one week (Philip et al., 2014), and mice with a mutation in RIPK1 that
ablates its kinase activity succumb within two weeks (Peterson et al., 2017). Although this seems
somewhat paradoxical given that Yp is predominantly an extracellular pathogen and injects Yops
to block phagocytosis, Yp can survive after uptake by macrophages (Pujol and Bliska, 2003,
2005). Furthermore, engagement of the T3SS apparatus during infection requires substantial
contact between the bacteria and host membranes such that death of the host cell may impair,
immobilize, or kill the bacteria embedded on the cell surface.
1.2.2.

Salmonella enterica serovar Typhimurium

Salmonella enterica serovar Typhimurium (S. Tm) is a Gram-negative enteric pathogen that
usually induces self-limiting gastroenteritis in humans following consumption of contaminated
food or water. S. Tm causes systemic disease in mice that mimics severe disease in humans
caused by S. Typhi, the causative agent of typhoid fever (Figure 1.6). Non-typhoidal Salmonella
spp. are the leading cause of foodborne associated mortality (Coburn et al., 2007; Malinda et al.,
2004), and Typhoidal Salmonella spp. cause more than 25 million annual cases of enteric fever
across the globe (Crump et al., 2004). During oral infection S. Tm breaches the intestinal barrier
by multiple mechanisms (Galán, 1996). S. Tm crosses via M cells (Jones et al., 1994) and
induces its own uptake through injection of effectors that stimulate membrane ruffling (Finlay and
Falkow, 1990; Wood et al., 1996; Zhou et al., 1999). Additionally, lamina propria dendritic cells
that sample the intestinal lumen can engulf S. Tm (Arques et al., 2009; Rescigno et al., 2001).
Motility, infection of the intestinal barrier, and gastroenteritis require the activity and expression of
Salmonella pathogenicity island-1 (SPI-1), which encodes one of the two T3SS used by S. Tm
(Galán and Curtiss, 1989). As a facultative intracellular pathogen, S. Tm remodels the membrane
bound compartment

into a hospitable, replicative niche, termed the Salmonella containing

vacuole (SCV) (Steele-Mortimer, 2008). The SPI-1 T3SS translocates a number of effectors
required for the establishment of the SCV which is decorated first with early endosomal markers
EEA1 and Rab5 and subsequently with Lamp1, Rab7, and vATPase (Smith et al., 2005; Steele-
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Mortimer et al., 1999). SPI-1 expression is downregulated (Boddicker and Jones, 2004), and SPI2 expression is induced by intracellular localization (Brown et al., 2005). SPI-2 encodes the
second T3SS which injects effectors required for SCV maturation, egress from the epithelium,
infection of phagocytes in the lamina propria, dissemination and persistence (Hensel et al., 1998;
Ochman et al., 1996).
Infection of the intestinal epithelium by S. Tm induces a delayed apoptosis mediated by
caspase-8 and -3 that is dependent on bacterial replication. SPI-1 induced flagellin is rapidly
detected by the NLRC4 inflammasome (Mariathasan et al., 2004; Miao et al., 2006) and is
therefore downregulated shortly after internalization to prevent detection and clearance by the
innate immune system (Boddicker and Jones, 2004; Lundberg et al., 1999). However, this gene
silencing is not absolute; a caspase-1/Naip5/NLRC4 inflammasome mediates preferential
expulsion of infected intestinal epithelial cells into the lumen and restricts intraepithelial bacterial
load (Rauch et al., 2017; Sellin et al., 2014). An NLRP3 inflammasome is also activated during S.
Tm infection by an unknown T3SS independent stimulus (Broz et al., 2010). Furthermore, S. Tm
strains engineered to express flagellin under the control of the SPI-2 promoter display significant
attenuation in vivo (Miao et al., 2010). S. Tm that successfully escape detection and rapid
pyroptosis will initiate delayed SPI-2-dependent, caspase-1 mediated pyroptosis between 12-24
hours after internalization (Lindgren et al., 1996; Monack et al., 2001; van der Velden et al.,
2000).
Cell death is essential for systemic control of S. Tm in vivo. Casp1/casp11-/- mice rapidly
succumb to infection (Broz et al., 2012). Pro-inflammatory IL-1β and IL-18 cytokine production
also contributes to S. Tm control (Raupach et al., 2006). Interestingly, due to redundancy in
substrate specificity, the individual inflammasome components NLRP3, ASC, and NLRC4 are not
strictly required for S. Tm. control in vivo despite their importance during in vitro pyroptosis (Broz
et al., 2010; De Jong et al., 2014; Lara-Tejero et al., 2006). However, infection of Nlrp3 and Nlrc4
dually ablated mice results in systemic bacterial loads comparable to those in casp1casp11-/mice (Broz et al., 2010).
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To investigate whether CARD19 plays a role in anti-microbial host defenses, we utilized in
vitro models of S. Tm and Yp infection and the in vivo model of Yp infection.

1.3. Figures
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Figure 1.1. Intrinsic and Extrinsic Apoptosis
Intrinsic apoptosis is induced when internal signals such as DNA damage, deprivation of growth
factors and cytokines, osmotic and oxidative stress trigger pro-apoptotic Bcl-2 family members.
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Pro-apoptotic Bcl-2 proteins promote cleavage of Bid to truncated Bid which mediates recruitment
of the pore forming protein Bax to the outer mitochondrial membrane (OMM) and insertion of Bak
into the OMM. Bax and Bak oligomerize and form pores that mediate in catastrophic loss of
mitochondrial membrane potential and cytochrome c release. Cytochrome c induces formation of
the apoptosome, a supramolecular activating complex for the executioner caspases-3, -6, and -7.
The executioner caspases cleave cellular targets leading to organized disassembly of the cell into
apoptotic bodies.
Extrinsic apoptosis is induced when death ligands such as TNF or Fas ligand bind their cognate
death receptors, inducing caspase-8 dimerization and auto-proteolysis to form the death inducing
signaling complex (DISC). Active caspase 8 cleaves caspase-3 and Bid, inducing terminal
apoptotic events, and the mitochondrial pathway of intrinsic apoptosis, respectively.
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Figure 1.2. Canonical and Non-Canonical Pyroptosis
Canonical pyroptosis is induced in response to a variety of stimuli that results in formation of a
supramolecular signaling complex composed of a sensor protein and caspase-1, sometimes an
adaptor protein, ASC. Following recruitment to the inflammasome, caspase-1 undergoes autoproteolysis and activation. Active caspase-1 cleaves pro-IL-1 family members and the pore
forming executioner gasdermin D. The N-terminus of gasdermin D forms a pore that facilitates IL1 release and lysis.
Non-canonical pyroptosis is induced by direct binding of LPS to caspase-11. Active caspase-11
cleaves gasdermin D, resulting in pore formation and potassium efflux that subsequently
activates the NLRP3/ASC/Caspase-1 inflammasome.
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Figure 1.3. Programmed Necrosis
During homeostasis and apoptosis, caspase-8 constitutively represses programmed necrosis by
preventing formation of the necrosome. When caspase-8 is inhibited in the presence of TNF or
LPS stimulation, the TNF receptor complex is internalized, promoting formation of necrosome
which contains RIPK1, RIPK3, and the adaptors TRADD and FADD. RIPK1 and RIPK3 are
activated by phosphorylation and subsequently phosphorylate the psuedokinase MLKL, which
forms lytic pores.
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Figure 1.4. Cross-talk between apoptosis, programmed necrosis, pyroptosis, and prosurvival pathways
Apoptosis, pyroptosis, programmed necrosis and pro-survival pathways are highly intertwined,
dynamically regulated, and coactivated.
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Figure 1.5. In vivo murine model of Yersinia pseudotuberculosis oral infection
Following oral gavage, Yersinia pseudotuberculosis (Yp) crosses the intestinal epithelium and
infects immune cells in the lamina propria. Yp causes localized infection of mesenteric lymph
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nodes and Peyer’s patches as well as systemic infection of distal sites such as the spleen and
liver. On a cellular level, injection of Yp effector proteins inhibits MAPK and NFκB-dependent prosurvival gene expression, resulting in activation of RIPK1/Caspase-8 dependent apoptosis.
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Figure 1.6. In vivo murine model of Salmonella Typhimurium oral infection
Following oral gavage, Salmonella Typhimurium (S. Tm) breaches the intestinal epithelium via M
cells and dendritic cells and by stimulating epithelial cells to phagocytose it. Infected intestinal
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epithelial cells are expelled into the intestinal lumen. S. Tm causes localized infection of the MLN
and Peyer’s Patches as well as systemic infection of distal sites such as the spleen and liver. On
a cellular level, detection of Salmonella flagellin and components of the T3SS by sensor proteins
activates formation of the inflammasome, resulting in caspase-1-dependent pyroptosis.
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CHAPTER 2: The mitochondrial protein CARD19 regulates apoptosis and pyroptosis
independently from cytokine production
2.1. Introduction
Regulated cell death is an evolutionarily conserved mechanism by which multicellular
organisms regulate fundamental biological processes ranging from tissue development to control
of microbial infection. Apoptosis and pyroptosis represent two distinct forms of regulated cell
death that are activated in response to diverse stimuli, including developmental signals (Mori et
al., 1995; Rodriguez et al., 1997), tissue stress or injury (Kajstura et al., 1996), and microbial
infection (Mariathasan et al., 2004; Miao et al., 2006; Monack et al., 1997; Zamboni et al., 2006).
While apoptosis was originally viewed as an immunologically quiescent or suppressive cell death
that occurs in the context of tissue homeostasis and development, certain stimuli, including
infections and chemotherapeutic agents, induce an inflammatory form of apoptosis that
contributes to anti-pathogen or anti-tumor immunity (Green et al., 2009; Kerr et al., 1972;
Uchiyama et al., 2017). Following certain intrinsic or extrinsic signals apoptosis is activated by
specific apoptotic caspases, which mediate organized disassembly of the cell via a process that
limits cellular permeability and enables phagocytosis of the dying cell (Nagata, 2018; Samali et
al., 1999). Alternatively, pyroptosis is a lytic form of regulated cell death characterized by
caspase-1- or -11-dependent plasma membrane disruption mediated by cleavage and activation
of the pore forming protein Gasdermin D, as well as release of interleukin-1 (IL-1) family
cytokines and other intracellular components (Fink and Cookson, 2005; Kayagaki et al., 2015;
Martinon et al., 2002; Shi et al., 2015a). However, inhibition of the receptor-proximal signaling
kinases TAK1 or IKK during infection by bacterial pathogens such as Yersinia, can trigger a
caspase-8-dependent apoptosis pathway that is also associated with gasdermin D cleavage
(Orning et al., 2018; Sarhan et al., 2018). These findings suggest a potential point of intersection
of cell death pathways previously viewed as distinct.
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The death domain superfamily includes more than forty essential mediators of signaling and
cell death pathways. Homotypic protein:protein interactions between family members facilitates
oligomerization and formation of supramolecular signaling platforms such as the death inducing
signaling complex (DISC) (Kischkel et al., 1995), apoptosome (Yang et al., 1998; Zou et al.,
1999), inflammasome (Broz et al., 2010; Mariathasan et al., 2004; Mariathasan et al., 2006;
Tenthorey et al., 2017), and necrosome (Li et al., 2012; Mompeán et al., 2018). Many DD
proteins have been characterized in the context of innate immunity, while others remain
unstudied. In previous investigations, we examined the roles of several death domain proteins
including the cysteine proteases caspases-8 and -1, and Receptor Interacting Protein Kinase-1
and -3 (RIPK1/3) (Peterson et al., 2017; Peterson et al., 2016; Philip et al., 2016; Philip et al.,
2014). Fortuitously, in our studies to understand and identify cell death regulators during bacterial
infection, we identified caspase activation and recruitment domain protein 19 or CARD19 (also
called Bcl10 interacting protein containing a CARD (BinCARD) (Chen et al., 2013; Woo et al.,
2004), or C9ORF89). CARD19 is a 17kD protein with an N-terminal CARD and C-terminal
transmembrane domain, and has been reported to localize to mitochondria and ER when
overexpressed in HeLa cells (Chen et al., 2013), but has not previously been linked to cell death.
Although an initial report identified an alternative human CARD19 isoform that negatively
regulates NF-κB activation in T cells through the Bcl10/MALT-1/CARMA1 complex (Woo et al.,
2004), this isoform lacks the C-terminal transmembrane domain and is not expressed in mice
(Brian Schaefer, unpublished data).
In this chapter, we characterize the role of CARD19 during apoptosis, pyroptosis, and
programmed necrosis. We show that CARD19 is a mitochondrial regulator of caspase-dependent
apoptosis and pyroptosis but not programmed necrosis. Additionally, we find that CARD19 acts
downstream of initiator and effector caspase cleavage during terminal events of cell death
including release of the alarmin, HMGB1, pore formation, and cell lysis, but is not required for
release of pro-inflammatory cytokines. Finally, we demonstrate a protective role for CARD19 in
anti-Yersinia host defense during in vivo bacterial infection.
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2.2. Results
2.2.1.

CARD19 localizes to the mitochondrial network

CARD19 is a small (183 aa) protein that contains an N- terminal CARD within the first 100
residues, and a predicted transmembrane domain spanning amino acids 122-142 (Figure 2.1A).
The domain architecture of CARD19 resembles that of another CARD-containing protein,
Mitochondrial Anti-Viral Signaling protein (MAVS), whose C-terminal transmembrane domain
localizes the protein to mitochondrial and peroxisomal membranes (Dixit et al., 2010; Kawai et al.,
2005; Seth et al., 2005). MAVS is most well-studied in the context of anti-viral immunity but has
also been reported to contribute to NLRP3-dependent release of IL-1β (Subramanian et al.,
2013). Interestingly, CARD19 transfected into HeLa cells colocalized with both mitochondrial and
ER resident markers (Chen et al., 2013). Consistent with this report, confocal microscopy
analysis revealed that approximately 90-95% of endogenous CARD19 overlapped with the
mitochondria-specific dye MitoTracker CMXRos in primary bone marrow derived macrophages
(BMDMs), and this was unaffected by infection or stimulation (Figure 2.1B-E). This was similar to
the levels of MAVS overlapping with this dye, suggesting these proteins have similar
localizations. We additionally examined localization of CARD19 to ER membranes and found that
CARD19 significantly overlapped with KDEL, a marker of ER proteins, under endogenous
conditions (Figure 2.2A, B) and during Yp infection (Figure 2.2C). However, approximately 90%
of ER staining overlapped with the mitochondria, suggesting that there is insufficient resolution to
separate these cellular compartments (Figure 2.2D, E). Deconvolution analysis following
confocal microscopy substantially enhanced the resolution and further demonstrated the
localization of CARD19 to the mitochondrial network (Figure 2.3). Consistently, MAVS and
CARD19 also exhibited a high degree of overlap in staining, although it was less than the costaining of either protein with MitoTracker CMXRos, suggesting that MAVS and CARD19 have
both shared and unique subdomains within the mitochondrial network (Figure 2.1B-D, 2.3A, B).
Lastly, we biochemically fractionated B6 and Card19-/- BMDMs into nuclear, cytoplasmic, and
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mitochondria enriched fractions. Consistent with the microscopy data, CARD19 and MAVS were
both found primarily in mitochondria-enriched subcellular fractions of untreated or Yp-infected and
Sts-treated BMDMs (Figure 2.4, red box).
2.2.2.

CARD19 is required for optimal levels of caspase-dependent cell death

To test the possible contribution of CARD19 to cell death during pyroptosis, we initially
investigated the kinetics of cell death in B6 and Card19-/- primary BMDMs in response to infection
by Salmonella enterica serovar Typhimurium (S. Tm) or treatment with LPS+ATP. S. Tm infection
of BMDMs induces the well-characterized NAIP/NLRC4/caspase-1 inflammasome pathway,
leading to pyroptosis and IL-1 cytokine release (Franchi et al., 2006; Kofoed and Vance, 2011;
Mariathasan et al., 2004; Miao et al., 2006). In contrast, LPS+ATP treatment activates the
NLRP3/ASC/caspase-1 inflammasome, which induces pyroptosis and IL-1 cytokine release via
activation of the P2X7 receptor and potassium efflux (Mariathasan et al., 2006; Muñoz-Planillo et
al., 2013; Perregaux and Gabel, 1994; Solle et al., 2001; Sutterwala et al., 2006). Intriguingly,
Card19-/- BMDMs displayed a striking and significant defect in cell death following either S. Tm
infection or LPS+ATP treatment, as measured by release of LDH (Figure 2.5A, B). Consistently,
Card19-/- BMDMs also showed a significant delay in the kinetics of membrane permeability, as
measured by a kinetic propidium iodide assay (Figure 2.5C, D).
Intriguingly, we also observed that Card19-/- BMDMs exhibited a significant defect in cell
death in response to infection by the gram-negative pathogen Yersinia pseudotuberculosis (Yp),
which activates cell-extrinsic caspase-8- and RIPK1-dependent apoptosis in response to Yp
blockade of IKK- and MAPK-signaling (Monack et al., 1997; Philip et al., 2014; Zhang et al.,
2005), as well as in response to the broad-spectrum kinase inhibitor staurosporine, which induces
cell-intrinsic apoptosis but can also activate caspase-8 in myeloid cells (Antonopoulos et al.,
2013; Bertrand et al., 1994; Jacobsen et al., 1996) (Figure 2.5E, F). These observations were
also mirrored by delayed PI uptake in Card19-/- BMDMs (Figures 2.5G, H). Strikingly, Card19-/BMDMs resisted cell death in response to all other apoptotic or pyroptotic stimuli we examined,
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including cycloheximide, etoposide, and noncanonical inflammasome activation (Figure 2.6A-D).
However, RIPK3-dependent programmed necrosis which occurs in response to LPS and the pancaspase inhibitor z-VAD-FMK (Degterev et al., 2008; He et al., 2011), was unaffected by
CARD19 deficiency (Figure 2.6E). Interestingly, we find that that Card19-/- BMDMs have a defect
in PI uptake in response to LPS+zVAD despite no difference in LDH release, suggesting that
CARD19 might mediate membrane repair or permeability (Figure 2.6F). Despite their similar
domain structure and subcellular localization (Figure 2.1A), MAVS did not play a role in
CARD19-dependent induction of cell death, indicating distinct functions for these mitochondrial
CARD-containing proteins (Figure 2.7). These findings indicate that CARD19 promotes cell death
following activation of multiple caspase-dependent pathways.
2.2.3.

CARD19 expression level is linked to cell lysis in peritoneal macrophages

If CARD19 is an important regulator of cell lysis, expression of CARD19 should correlate with
the extent of cell lysis in response to different pyroptotic or apoptotic stimuli in distinct cell
populations. To test whether CARD19 might have a broader role in regulating cell lysis in wildtype cells, we analyzed Card19 expression levels in published transcriptional profiling datasets
provided by the Immunological Genome Project (Ericson et al., 2014; Shay and Kang, 2013).
Interestingly, multiple transcriptional datasets reported that thioglycolate-elicited peritoneal cell
populations had substantially higher CARD19 expression than other immune cells (Figure 2.8A),
(Ericson et al., 2014). Intriguingly, thioglycolate-elicited peritoneal cells (Figure 2.8B) also
exhibited significantly higher levels of cytotoxicity following either Yp or Stm infection in
comparison to resident peritoneal macrophages isolated from PBS-injected control mice (Figure
2.8C, D). This difference closely matched the differences in cytotoxicity between Wt and Card19-/BMDMs (Figure 2.5), as well as thioglycolate-elicited peritoneal cells from Wt and Card19-/- mice
(Figure 2.8E, F). The results suggest that CARD19 levels are associated with enhanced cell lysis
in response to apoptotic and pyroptotic stimuli in a variety of innate immune cells.
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The Card19-/- mice were initially generated on the 129SvEv background and extensively
backcrossed to B6 (discussed in Chapter 6: Methods). SNP genotyping analysis of multiple
independent Card19-/- mice in our colony demonstrated that only a 6 MB region on one side of the
Card19 locus retained the chromosomal region from the 129 background. None of the loci in this
region have a known role in regulation of cell death (Figure 2.9A). Importantly however, BMDMs
from 129SvEv as well as Card19+/- mice exhibited wild-type levels of cell death in response to all
stimuli we tested, and additional crossing of Card19-/- onto B6 followed by intercrossing of the
heterozygous progeny demonstrate that the phenotype of Card19-/- BMDMs is unlikely to be the
result of a passenger mutation at a distal site (Figure 2.9B-D). Altogether these data suggest
CARD19 is a previously uncharacterized regulator of cell lysis. We next sought to examine
whether CARD19 mediated cell death through perturbing mitochondrial dynamics.
2.2.4.

CARD19 does not influence mitochondrial dynamics

Mitochondria are essential regulatory platforms for intracellular signaling, respiration,
homoeostasis, death. In untreated BMDMs, loss of CARD19 does not significantly impact
mitochondrial area as measured by quantification of MitoTracker staining (Figure 2.10A).
Mitochondrial proteins direct respiration and homeostatic events. We tested whether CARD19
deficiency impacted mitochondrial respiration by utilizing a Seahorse XF mito-stress test in
resting and LPS-stimulated BMDMs. Seahorse assays measure changes in oxygen consumption
rate to determine cellular levels of ATP-dependent respiration, maximal respiration, and nonmitochondrial respiration (Figure 2.10D, E). We did not observe consistent differences in either
oxygen consumption rate between untreated or LPS primed B6 and Card19-/- BMDMs (Figure
2.10B, C), indicating that CARD19 does not play a role in mitochondrial respiration. Together,
these data suggest CARD19 does not influence mitochondrial homeostasis or respiration.
Mitochondria are important mediators of intrinsic apoptosis (Figure 1.1). Cleavage of Bcl-2
family member Bid to truncated Bid (tBid) activates it to induce conformational changes in the
pore forming proteins Bax and Bak. Bax is constitutively localized to the cytosol but activation by
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tBid and induces translocation and insertion into the outer mitochondrial membrane (OMM) (Kim
et al., 2009; Willis et al., 2005). At steady-state, Bak is localized at mitochondria but activation
induces insertion of key helices into the OMM (Kim et al., 2009; Oh et al., 2010; Wei et al., 2000).
Bax and Bak form pores in the OMM, potentiating catastrophic loss of mitochondrial membrane
potential and cytochrome c release, ultimately promoting apoptosome formation and apoptosis
execution (Annis et al., 2005; Bleicken et al., 2013; Jürgensmeier et al., 1998; Kim et al., 2009; Li
et al., 1997; Subburaj et al., 2015; Wei et al., 2000). We investigated whether CARD19 mediated
the mitochondria-associated events during cell death by examining Bax and Bak in biochemically
fractionated BMDMs. We did not find a defect in Bax translocation to mitochondria, or expression
of Bax or Bak in mitochondrial fractions (Figure 2.11, red boxes). Interestingly, these is slightly
more Bax, Bak, and cytochrome c present in Card19-/- mitochondria-enriched fractions, however,
we also see increased COX IV which serves as the mitochondrial loading control. These results
imply CARD19 does not regulate cell death events at mitochondria.
2.2.5.

CARD19 is not required for caspase cleavage and activation

In the current literature, regulators of cell death act at the level of caspase activation or
assembly of caspase-activating complexes. We therefore sought to test whether CARD19 was
required for caspase processing and cleavage of downstream targets. Pyroptosis is mediated by
activation of caspase-1 or -11 (Broz and Dixit, 2016; Martinon et al., 2002; Martinon et al., 2007),
which cleave gasdermin D, thereby triggering cell lysis by enabling formation of oligomeric Nterminal GSDMD pores in the plasma membrane (Aglietti et al., 2016; Kayagaki et al., 2015; Liu
et al., 2016; Shi et al., 2015a). Unexpectedly, despite the significant reduction in cytotoxicity in
Card19-/- cells, processing of caspase-1 as evidenced by the p20 band was equivalent in B6 and
Card19-/- cells 15 minutes post-infection, a timepoint at which cell death is virtually undetectable
in both genotypes (Figure 2.12A, red boxes). Moreover, B6 cells released significant amounts of
cleaved caspase-1 p20 into cell supernatants at later timepoints, in contrast to Card19-/- BMDMs
(Figure 2.12A, blue boxes). This was consistent with the reduced levels of pyroptosis in Card19-
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/-

cells in response to S. Tm infection and corroborated by increased amounts of cleaved

caspase-1 retained in whole cell lysates of Card19-/- BMDMs (Figure 2.12A). Similarly, initial
processing of gasdermin D to the cleaved p30 form was equivalent in B6 and Card19-/- cell
lysates (Figure 2.12A, green boxes), while the release of processed gasdermin D p30 into the
supernatant was significantly reduced in Card19-/- cells (Figure 2.12A, brown boxes). Thus,
CARD19 is not required either for caspase-1 activation, or the cleavage of caspase-1 targets. It is
possible that CARD19 could be involved in the stability or maintenance of caspase-1 activity,
however, Card19-/- lysates infected with S. Tm display increased amounts of cleaved caspase-1
p20 relative to B6 lysates.
Cell-extrinsic apoptosis is mediated by oligomerization and auto-processing of caspase-8
(Figure 1.1) (Kischkel et al., 1995; Wallach et al., 1997). Active caspase-8 directly cleaves its
pro-apoptotic downstream targets, including the Bcl-2 family member Bid (Denecker et al., 2001;
Li et al., 1998), and the executioner caspases-3 and -7. Similar to our findings with caspase-1, we
did not find a defect in the cleavage of apoptotic caspases or their substrates in Card19-/- BMDMs
in response to Yp infection and staurosporine treatment (Figure 2.12B, C). Card19-/- BMDMs
showed robust cleavage of caspase-8 to the p25 band (Figure 2.12B, red boxes), as well as
processing of downstream apoptotic substrates, including Bid cleavage to truncated bid (Figure
2.12B, blue boxes), caspase-3 cleavage to the p17 band (Figure 2.12B, green boxes), the
caspase-3 target poly-ADP ribose polymerase (PARP) cleavage to the p100 band (Figure 2.12B,
brown boxes), and pore-forming protein GSDME also known as DFNA5 cleavage to the p30 Nterminus (Figure 2.12C, blue boxes) (Rogers et al., 2017; Sarhan et al., 2018). Cleavage of
caspase-3 in Card19-/- in apoptotic-inducing conditions (Figure 2.12B, green boxes) suggest that
CARD19 may not involved in mitochondria activities that promote apoptosome formation and
caspase-3 cleavage. Intriguingly, we also observed gasdermin D processing to the p30 Nterminal bands in response to Yp infection as well as Sts treatment, which was also independent
of CARD19 (Figure 2.12C, red boxes).
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Altogether, these data suggest that CARD19 is not required for activation and cleavage of
caspase and their cellular targets during apoptosis and pyroptosis. Importantly, direct comparison
of caspase-1 and gasdermin D processing in response to multiple stimuli revealed that Card19-/cells had reduced release of cleaved caspase-1 (Figure 2.12D, blue boxes) and N-terminal
gasdermin D into the supernatant (Figure 2.12D, brown boxes), and correspondingly increased
retention in cell lysates (Figure 2.12D, red boxes and green boxes, respectively), consistent
with reduced terminal lysis of the cells in the absence of CARD19 (Figure 2.5). Card19-/- BMDMs
had wild-type levels of caspase-8 activity in response to either Yp infection or Sts treatment,
confirming that CARD19 does not affect caspase activity itself (Figure 2.12E). Together, these
findings demonstrate that CARD19 is dispensable for caspase activation and substrate cleavage,
and therefore likely regulates cell lysis downstream of caspase activation. We therefore examined
whether CARD19 mediated terminal events during cell death.
2.2.6.

CARD19 regulates release of the intracellular alarmin HMGB1

Immunogenic cell death induces the release of danger associated molecular patterns
(DAMPs), alarmins, and cytokines that mediate activation and recruitment of innate and adaptive
immune cells and production of an inflammatory milieu that is inhospitable to pathogens (Garg et
al., 2012; Schiraldi et al., 2012). Some of these mediators include ATP (Marteau et al., 2004;
Schnurr et al., 2000), mitochondrial DNA (Caielli et al., 2016; Collins et al., 2004), heat shock
proteins (Chen et al., 1999; Galdiero et al., 1997), HMGB1 (Messmer et al., 2004; Scaffidi et al.,
2002), and IL-1 cytokines (Ben-Sasson et al., 2009). CARD19 regulates apoptosis and pyroptosis
downstream of caspase activation and cleavage; therefore, we investigated whether CARD19
mediated HMGB1 and cytokine release.
HMGB1 is a nuclear chromatin-associated protein that acts as an alarmin when released
from cells upon loss of plasma membrane integrity (Andersson et al., 2000; Bell et al., 2006). As
expected in B6 cells, S. Tm or LPS+ATP treatment led to significant HMGB1 release into the
supernatant by one hour post-infection (Figure 2.13A, red box, + lanes), and by 4 hours post-
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exposure to Yp or Sts (Figure 2.13A, blue box, + lanes). In contrast, Card19-/- cells exhibited
significantly delayed release of HMGB1 for each respective timepoint (Figure 2.13A, red and
blue boxes, - lanes), consistent with reduced levels of membrane permeability in these cells
(Figure 2.5). HMGB1 levels in the supernatant of Card19-/- cells were virtually undetectable at
one hour in response to S. Tm or LPS+ATP, and minimal at 4 hours in response to Yp or Sts
(Figure 2.13A, red and blue boxes, - lanes). To obtain insight into the dynamics of HMGB1
release from cells, we analyzed HMGB1 release by confocal microscopy of Wt and Card19-/- cells
following exposure to Sts. We observed three morphologies of HMGB1 staining – nuclear, in
which the majority of HMGB1 was located in the nucleus; cellular, in which HMGB1 was absent
from the nucleus but still relatively contained within the confines of a cell; and extracellular, in
which a cloud of HMGB1 was detectable surrounding what was likely the remnants of apoptotic
cells and cellular debris. Notably, and consistent with the delay in HMGB1 release we observed in
bulk cell populations, Card19-/- cells exhibited a delay in HMGB1 release from the nucleus
(Figure 2.13B, C), and while B6 BMDMs exhibited a high frequency of HMGB1 cloud formation,
these clouds were largely absent from Sts-treated Card19-/- cells (Figure 2.13B white arrows,
quantified in Figure 2.13D). Altogether, these findings indicate that CARD19 facilitates cell lysis
and release of intracellular contents during induction of cell death triggered by caspase-1 or
caspase-8 activation.
2.2.7.

CARD19 does not mediate release of cytokines or regulate hyperactivation

We next examined whether CARD19 regulated cytokine release. Extracellular PAMPs bind
TLRs and stimulate production of IL-1 genes via NFκB signaling, priming the cells. Subsequently,
intracellular microbial products activate inflammasome, promoting caspase-1 cleavage of IL-1
(Martinon et al., 2002). Consistent with our findings that CARD19 does not regulate the
proteolytic activity of caspase-1, CARD19-deficient cells released wild-type levels of IL-1
cytokines in response to S. Tm, LPS+ATP, or infection with the ΔyopEJK Yp strain, which triggers
a caspase-11/NLRP3-dependent pathway of IL-1 cytokine release (Zwack et al., 2017; Zwack et
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al., 2015) (Figure 2.14A, B). These data indicate that CARD19 does not regulate the secretion of
the IL-1 family cytokines IL-1α and IL-1β, which depends on caspase-1 and/or -11 activity and is
thought to require formation of a GSDMD pore in the plasma membrane (Evavold et al., 2018;
Heilig et al., 2017; Hogquist et al., 1991; Kuida et al., 1995). These data indicate that the absence
of CARD19 decouples secretion of IL-1β from pyroptosis, which normally occurs in response to
these

stimuli.

CARD19

has

been

suggested

to

be

a

negative

regulator

of

the

Bcl10/MALT1/CARMA1 complex that mediates NF-κB signaling following TCR activation (Woo et
al., 2004). However, we did not observe any impact of endogenous CARD19 deficiency on
secretion of the canonical NF-κB dependent cytokines IL-6, TNF, and IL-12p40, suggesting that
CARD19 does not generally regulate expression of NF-κB-dependent genes (Figure 2.14C-E).
Altogether, these findings suggest that in cells undergoing pyroptosis, CARD19 separates release
of intracellular markers of cell lysis such as LDH and HMGB1 to the release of caspase-1dependent cytokines.
During hyperactivation, cells release IL-1β while remaining viable and without undergoing
significant cell lysis (Evavold et al., 2018; Heilig et al., 2017; Wolf et al., 2016). Gasdermin D is
required for IL-1β secretion in this context, but the mechanism by which IL-1β is released from
gasdermin D pores without inducing lysis is not understood (Evavold et al., 2018; Wolf et al.,
2016). We investigated whether differences in CARD19 protein expression is correlated with
differences in lysis and hyperactivation by infecting B6 BMDMs with a Staphylococcus aureus
mutant that induces hyperactivation (Evavold et al., 2018; Wolf et al., 2016). As expected,
BMDMs infected with ΔoatA S. aureus released significant IL-1β without significant cell death
(Figure 2.14G, H). If CARD19 protein expression correlated with levels of cell death, we might
expect to see a loss or decrease of CARD19 expression in the hyperactivation conditions which
do not undergo lysis to the same extent as the S. Tm control (Figure 2.14G). However, CARD19
expression did not differ between untreated, ΔoatA and S. Tm-infected BMDMs (Figure 2.14F,
blue box), which indicates that CARD19 protein expression does not correlate with levels of cell
death. Interestingly, ΔoatA-infected cells exhibited significantly lower levels of gasdermin D
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processing (Figure 2.14F, red box), suggesting that hyperactivation may be regulated at the step
of gasdermin D processing and that differences in gasdermin D processing or membrane
insertion may underlie the distinction between hyperactivation and cell lysis. It further suggests
that CARD19 is not involved in the initial decision to enter hyperactivation because we see no
defect in gasdermin D cleavage in the Card19-/- cells (2.12A green boxes, 2.12C red boxes,
2.12D green boxes).
2.2.8.

CARD19 mediates anti-Yersinia host defense

Thus far, we have identified CARD19 as a significant contributor to apoptosis and pyroptosis
in vitro. Cell death is an essential part of the immune response to bacterial pathogens in vivo;
therefore, we sought to investigate whether CARD19 contributes to anti-pathogen responses to
oral infection with Yp. Consistent with findings that mice lacking essential mediators of cell death
are more susceptible to bacterial infection (Peterson et al., 2017; Peterson et al., 2016; Philip et
al., 2014; Weng et al., 2014), Card19-/- mice were more susceptible to oral Yp infection and had a
defect in controlling systemic Yp tissue burdens in organs such as the spleen and liver (Figure
2.15A, B). Yp-infected Card19-/- mice exhibited increased splenomegaly (Figure 2.15C, D),
suggesting either failure to control infection and elevated recruitment of inflammatory cells to the
spleen, or a failure of innate cells to undergo cell death during bacterial infection in vivo. Card19-/mice had similar levels of serum IL-6 and IL-12, although they had increased levels of TNF
(Figure 2.15E), consistent with increased bacterial burdens in vivo and the finding that CARD19
itself is not required for cell-intrinsic inflammatory cytokine production. These data demonstrate
an important role for CARD19 in host defense against oral Yersinia infection, providing a further
link between regulation of cell death and anti-bacterial host defense.

2.3. Discussion
Our work identifies a previously undescribed role for CARD19 in the execution of
macrophage cell death following multiple apoptotic and pyroptotic stimuli (Figure 2.5, 2.6).
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CARD19 is a 183 amino acid protein containing a CARD within the first 100 amino acids, and a
C-terminal transmembrane domain at positions 122-142 (Figure 2.1A). This domain architecture
resembles another mitochondrial CARD-containing protein, MAVS (mitochondrial anti-viral
signaling), which is an important regulator of antiviral responses (Kawai et al., 2005; Seth et al.,
2005). Notably, CARD19 and MAVS significantly co-localized with each other and the
mitochondrial dye MitoTracker CMXRos. MAVS has been reported to regulate pyroptosis in
certain settings (Subramanian et al., 2013) in addition to its primary function as an anti-viral
response regulator. We did not observe an effect of MAVS deficiency on either pyroptosis or
apoptosis under conditions in which Card19-/- BMDMs showed a robust and consistent defect
(Figure 2.7), indicating that the role of CARD19 in promoting cell death is independent of
potential interactions with MAVS.
This study establishes CARD19 as general mediator of RCD in response to multiple apoptotic
and pyroptotic stimuli, including canonical and non-canonical inflammasome activation and cellextrinsic apoptosis. Despite this enhanced cell survival in response to multiple distinct caspaseactivating stimuli (Figure 2.5, 2.6), we observed no defect in caspase processing between wildtype and Card19-/- cells (Figure 2.12A red boxes, 2.12B red and green boxes, 2.12D red box),
demonstrating that CARD19 is not required for caspase processing. Both caspase-1 and
caspase-8 can be active as unprocessed homo- or heterodimers, raising the possibility that
measurement of processed caspase-1 or -8 does not necessarily reflect the activity of these
enzymes in B6 and Card19-/- cells (Broz et al., 2010; Guey et al., 2014; Oberst et al., 2010; Pop
et al., 2011). Furthermore, the cleaved p20 form of caspase-1 that is used to measure caspase
activity can also indicate a negative regulatory function of caspase-1 (Boucher et al., 2018).
Importantly however, CARD19-deficiency did not affect caspase-1 or -8-dependent substrate
cleavage (Figure 2.12A green boxes, 2.12B blue and brown boxes, 2.12C red and blue
boxes, 2.12D green box) or caspase-8 activity (Figure 2.12E), demonstrating that CARD19
regulates cell death downstream of caspase activity and target cleavage.
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The inability of cells to undergo cell death during bacterial infection is strongly associated with
poor in vivo outcomes. Mice lacking key components of the apoptotic or pyroptotic pathways
including caspase-8 and caspase-1 are highly susceptible to oral Yp and S. Tm. infections,
respectively (Jorgensen et al., 2016; Miao et al., 2010; Peterson et al., 2017; Philip et al., 2014).
Consistent with these findings, Card19-/- mice were also more susceptible to oral Yersinia
infection (Figure 2.15), providing evidence that CARD19-dependent regulation of cell death is
important for anti-bacterial defense. As CARD19 plays a role in the induction of multiple caspasedependent cell death pathways, future studies will elucidate whether CARD19-dependent cell
death is important for in vivo host protection against other types of infections or biological
stresses.
Particularly surprising was our observation that IL-1α and IL-1β secretion, which requires
caspase-1 activation and formation of a gasdermin D pore, was unaffected by CARD19deficiency, despite a significant defect in cell death in response to a broad spectrum of stimuli that
induce pyroptosis in BMDMs (Figure 2.14). These data demonstrate that CARD19 uncouples
pyroptosis and IL-1 cytokine secretion in macrophages. While IL-1 cytokine release in the setting
of caspase-1/11-mediated cell death has been viewed as a defining feature of pyroptosis
(Bergsbaken et al., 2009; Fink and Cookson, 2006), several lines of evidence indicate that
cytokine secretion and cell death can be decoupled. Certain cell types or stimuli can mediate
caspase activation and IL-1β release in the absence of overt cell lysis (Chen et al., 2014; Gaidt et
al., 2016; Zanoni et al., 2016), a state that has been termed ‘hyperactivation’ (Evavold et al.,
2018; Zanoni et al., 2016). For example, specific hyperactivating stimuli, such as N-acetylglucosamine from bacterial peptidoglycan, or the host-derived oxidized phospholipid oxPAPC,
can induce IL-1 cytokine release without triggering cell death (Wolf et al., 2016; Zanoni et al.,
2016). Neutrophils undergo NLRC4-dependent caspase-1 activation and IL-1β release in
response to Salmonella infection without undergoing cell lysis, and human monocytes contain
constitutive levels of active, processed caspase-1, enabling them to secrete cleaved IL-1β in
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response to LPS alone and remain viable (Chen et al., 2014; Gaidt et al., 2016; Netea et al.,
2009).
Surprisingly, it was recently demonstrated that gasdermin D pores are required for secretion
of IL-1 family cytokines by viable hyperactivated cells as well as release of intracellular contents
during lytic cell death in the setting of pyroptosis (Evavold et al., 2018; Heilig et al., 2017). This
implies that distinct cell types and stimuli are able to engage an alternative cell fate decision or a
terminal checkpoint that separates hyperactivation, with IL-1 release by viable cells, from
pyroptosis, where IL-1 secretion occurs concomitantly with HMGB1 and LDH release, denoting
cell lysis. These findings also imply that this cell fate checkpoint involves generation of
quantitatively or qualitatively distinct gasdermin D pores that distinguish IL-1 family cytokine
secretion from terminal cell lysis. Indeed, gasdermin D-induced pore formation and terminal lysis
can be kinetically separated, suggesting a potential step at which this type of regulation could
occur (DiPeso et al., 2017). Our finding that the hyperactivating stimulus ΔoatA S. aureus triggers
lower levels of gasdermin D cleavage (Figure 2.14F, red box), that are nevertheless compatible
with release of IL-1β, supports this model. While certain cell types and stimuli are able to engage
this checkpoint, our findings uncover the CARD19 as the first cellular factor that specifically
regulates gasdermin D-induced cell death downstream of caspase activation and gasdermin D
cleavage.
Our data thus far identifies CARD19 as a mitochondrial regulator of both apoptosis and
pyroptosis. These finding are fundamentally surprising, in part, because these pathways have
generally been considered to be distinctly regulated. We originally expected that a dual regulator
of apoptosis and pyroptosis would act to modulate the initiating stimuli leading to caspase
cleavage. Instead, we found that CARD19 acts downstream of caspase activation and gasdermin
cleavage (Figure 2.12). These results imply that apoptosis and pyroptosis may be more
interconnected than previously thought (Fink and Cookson, 2005). Additionally, it’s unclear how a
mitochondrial protein regulates terminal events such as HMGB1 release during cell death (Figure
2.13). Although we did not find a role for CARD19 in mitochondrial oxidative phosphorylation
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(Figure 2.10) or recruitment of the Bcl-2 pore forming protein Bax to mitochondrial enriched
fractions (Figure 2.11, red boxes), we have not exhaustively investigated the role of CARD19 in
mitochondrial events and activities. Mitochondrial ROS production, calcium and ion flux, and loss
of mitochondrial membrane potential occur during cell death (Tait and Green, 2013). It is possible
that CARD19 could potentially regulate one of these events or another mitochondrial activity that
promotes cell death. Chapter 4 will explore preliminary data investigating the mechanism by
which CARD19 may promote death, and future investigations will further examine whether
CARD19 acts on mitochondria to mediate cell death.
In summary, the data presented in Chapter 2 have identified a identify a novel mediator of
apoptosis and pyroptosis, CARD19, as a critical regulator of RCD downstream of caspase
activation and cleavage. Altogether, this study contributes to body of literature describing the
biological significance of key RCD mediators during in vivo bacterial infections. In Chapter 3, we
identify a previously unappreciated role for the pyroptotic executioner gasdermin D during
apoptosis. In Chapter 4, we will investigate the molecular mechanisms by which CARD19
mediates a terminal checkpoint during cell death.

2.4. Figures
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Figure 2.1. CARD19 localizes to the macrophage mitochondrial network
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(A) Domain structure of CARD19 and MAVS. CARD, caspase activation and recruitment domain.
TM, transmembrane domain. PRR, proline-rich region.
(B, E) Confocal microscopy images of (B) untreated or (E) Yp infected (MOI 10, 2 hrs) B6,
Card19-/-, and Mavs-/- BMDMs stained with MitoTracker CMXRos, anti-CARD19 (green), antiMAVS (blue), and DNA (Hoechst). Images are representative of 3 independent experiments.
Scale bar 20 microns.
(C) Quantification of the percentage of CARD19 or MAVS staining that overlaps with MitoTracker
CMXRos in B6 BMDMs. 100-150 cells per experiment were quantified as described in Chapter 6:
Materials and Methods; each dot represents a single cell.
(D) Quantification of the percentage of CARD19 staining that overlaps with MAVS in B6 BMDMs.
100-150 cells per experiment were quantified as described in Chapter 6: Materials and
Methods; each dot represents a single cell.
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Figure 2.2. CARD19 overlaps with the ER
(A, C) Confocal microscopy images of (A) untreated or (C) Yp infected (MOI 10, 2 hrs) B6 and
Card19-/- BMDMs stained with anti-KDEL (red), anti-CARD19 (green), actin (Phalloidin), and DNA
(Hoechst). Scale bar 10 microns.
(B) Quantification of the percentage of CARD19 staining that overlaps with KDEL in B6 BMDMs.
100-150 cells per experiment were quantified as described in Chapter 6: Materials and
Methods; each dot represents a single cell.
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(D) Confocal microscopy images of untreated B6 macrophages stained with MitoTracker
CMXRos (Red), anti-KDEL (green), and DNA (Hoechst). Scale bar 20 microns, inset scale bar 10
microns.
(E) Quantification of the percentage of KDEL staining that overlaps with MitoTracker CMXRos.
100-150 cells per experiment were quantified per experiment as described in Chapter 6:
Materials and Methods; each dot represents a single cell.
Images and quantification are representative of 3 independent experiments.
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Figure 2.3. CARD19 localizes to mitochondrial network
(A) Confocal microscopy images of B6 and Card19-/- BMDMs stained with MitoTracker CMXRos,
CARD19, MAVS, and DNA (Hoechst). Images were deconvolved with Huygens Professional
using the CMLE algorithm, with SNR:25 and 40 iterations. Inset shown before and after
deconvolution. Scale bar 10 microns, inset scale bar 2.5 microns.
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(B) Quantification of the fraction of CARD19 and MAVS that overlap with MitoTracker before and
after deconvolution as described in Chapter 6: Materials and Methods. Images and
quantification representative of 2 independent experiments
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Figure 2.4. CARD19 localizes to mitochondria enriched fractions
(A) Mitochondrial Fractionation Scheme. P = Pellet, S = Supernatant, P0.95 = Pellet from a
0.95g spin. a, b = differentiates between two identical spins. Supernatants were aspirated
and BMDMs were harvested in cold PBS. Under cell death conditions, supernatants were added
to PBS to capture non-adherent cells. BMDMs were washed 1x in cold PBS, 1500 RPM. Cell
pellet was resuspended in Resuspension Buffer (RSB) plus protease and phosphatase inhibitors
(+p/p). Cells were swelled on ice for 30 min. Cells were disrupted with a Potter-Elvehjem
homogenizer at 4000 RPM until 65-75% of cells were disrupted (90-180 strokes). Mitochondrial
Extraction Buffer (MEB)+p/p was added and spun down at 950g to pellet the nucleus (P0.95).
P0.95 was resuspended in Nuclear Wash Buffer (NWB)+p/p and spun down at 8,500
RPM for 1 min, repeated 3x. P8.5 was resuspended in Nuclear Extraction Buffer
(NEB)+p/p and vortexed at full speed at 4°C for 30 min. The nuclear fraction was spun at
full speed (~15,000g) for 20 min. S15 was recovered as the nuclear fraction. S0.95a was
spun again at 950g to remove additional nuclear debris.
S0.95a was spun again at 950g to remove residual nuclear contamination. S0.95b was spun at
10,000g to pellet mitochondria. S10 was recovered as cytoplasmic fraction. P10a was washed 2x
with MEB+p/p and spun at 10,000g for 10 min. P10b was resuspended in MEB+p/p as the
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mitochondrial fraction. Protein concentration was measured using BCA assay and appropriate
buffer (nuclear - NEB, mitochondria - MEB, cytoplasmic 4:3 RSB:MEB). Fractions were
normalized to 1 mg/mL with appropriate buffer and 1x sample buffer. All spins were conducted at
4°C.
(B) CARD19 localizes to mitochondria enriched fractions (red box). Subcellular fractions were
isolated from B6 (CARD19+) or Card19-/- (CARD19-) BMDMs following no treatment or two hours
after Yp infection or Sts treatment. Isolated fractions were assayed by western blotting for
CARD19, MAVS, Cytochrome C Oxidase Subunit IV (COX IV), Calnexin, HDAC1, and Tubulin.
Blots are representative of two independent experiments.
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Figure 2.5. CARD19 is required for maximal caspase-dependent cell death
B6 or Card19-/- BMDMs were infected with Salmonella Typhimurium (S. Tm) or Y.
pseudotuberculosis (Yp), or treated with LPS+ATP or staurosporine (Sts), as indicated, and the
kinetics of cell death was assayed by release of lactate dehydrogenase (LDH) (A, B, E, F) or
propidium iodide (PI) uptake (C, D, G, H). Each figure is representative of three or more

50

independent experiments. LDH release was assayed at specific times post-infection. PI uptake
was measured over a two or ten-hour timecourse with fluorometric measurements taken at 2.5
minute (C, D) or 10 minute (G, H) intervals. Mean ± SEM of triplicate wells is displayed. Each
panel is representative of three or more independent experiments. *** p < 0.001, ** p < 0.01, * p <
0.05. n.s. not significant, analyzed by 2-way ANOVA with Bonferroni multiple comparisons posttest.
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Figure 2.6. CARD19 mediates non-canonical pyroptosis but not programmed necrosis
B6, Card19-/-, and Casp11-/- BMDMs were treated with (A) cycloheximide+LPS (B) etoposide (C)
Pam3CSK+E. coli or (D, E) z-VAD-FMK + LPS and cell death was assayed by (A-D) LDH release
or (E) PI uptake. BMDMs were treated, supernatants were harvested from triplicate wells at
indicated time points and measured for cytotoxicity. PI uptake was measured over an eight-hour
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timecourse with fluorometric measurements taken at 10 minute intervals. Mean ± SEM of
triplicate wells is displayed. Each figure is representative of 2 or more independent experiments.
*** p < 0.001, ** p < 0.01, * p < 0.05. n.s. not significant. 2-way ANOVA with Bonferroni multiple
comparisons post-test.
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Figure 2.7. MAVS is not required for CARD19-mediated cell death
B6, Card19-/-, Mavs-/-, or isogenic Mavs+/+ BMDMs were infected with (A) Salmonella
Typhimurium (S. Tm) (B) treated with LPS+ATP (C) infected with Y. pseudotuberculosis (Yp) or
(D) treated with staurosporine (Sts), as indicated, and the kinetics of cytotoxicity assayed by
release of lactate dehydrogenase (LDH). Mean ± SEM is displayed. Data are representative of
two independent experiments. *** p < 0.001, ** p < 0.01, * p < 0.05. 2-way ANOVA with
Bonferroni multiple comparisons post-test.
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Figure 2.8. CARD19 expression level is linked to cell lysis in peritoneal macrophages
(A) RNAseq from Immgen ULI RNAseq showing CARD19 expression in multiple immune cell
populations.
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(B) B6 and Card19-/- mice were injected with 4% aged thioglycolate or PBS. 48 hrs later, PECS
were harvested, RBC lysed, counted and plated in triplicate overnight at 37°C. PBS PECS were
pooled prior to plating. Cells were washed with PBS to remove non-adherent cells and infected
with Yp or S. Tm (MOI 10) or treated with staurosporine (10 uM). Cytotoxicity was measured by
LDH release at indicated time points. *** p < 0.001, ** p < 0.01, * p < 0.05. n.s. not significant. 2way ANOVA with Bonferroni multiple comparisons post-test. Graphs are representative of two
independent experiments with 3-6 mice per group, per genotype.
(C, D) B6 mice were injected with PBS or 4% aged thioglycolate as described above. PBS: mean
± SEM for technical replicates of 3 pooled B6 mice are graphed due to low cell yields from the
peritoneum of PBS mice. Thioglycolate: means of technical replicates for 3 B6 mice ± SEM
graphed. Cells were infected with (C) S. Tm or (D) Yp.
(E, F) B6 and Card19-/- mice were injected with 4% aged thioglycolate. The means of technical
replicates for 4 B6 and Card19-/- mice ± SEM are graphed. Cells were infected with (E) S. Tm or
(F) Yp.
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Figure 2.9. Card19-/- BMDMs are phenotypically distinct from 129/Sv and Wt BMDMs
(A) Genetic map indicating ±10 MB flanking the Card19 gene locus. A 6 MB region on the 5’ end
of the CARD19 locus (shown by the yellow bar) is derived from original 129SvEv eggs used to
generate the Card19-/- line. Myeloid expressed genes are shown in red bars.
(B-D) B6, Card19-/-, Card19+/-, and 129/Sv BMDMs were infected with S. Tm or Yp or treated with
Sts, as indicated, and LDH release was measured from triplicate wells for each data point. Each
panel is representative of 2 or more independent experiments. Mean ± SEM is displayed. *** p <
0.001, ** p < 0.01, * p < 0.05. n.s. not significant. 2-way ANOVA with Bonferroni multiple
comparisons post-test.
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Figure 2.10. CARD19 is not involved in mitochondrial respiration
(A) Quantification of the area of MitoTracker CMXRos staining in untreated B6 and Card19-/BMDMs as a percentage of total cell area as measured by actin staining (Phalloidin) as described
in Chapter 6: Materials and Methods. Each dot represents a single cell. 100-150 cells were
quantified per experiment. Representative of three experiments.
(B) Schematic of Seahorse Assay Oxygen Consumption Rate. Oxygen Consumption Rate (OCR)
is read at baseline and after injection of oligomycin, FCCP, and Rotenone/Actimycin A, which
allows for measurement of basal respiration, ATP production, maximal respiration, and nonmitochondrial respiration, respectively.
(C) Schematic of the electron transport chain during oxidative phosphorylation. Oligomycin
inhibits the proton pump. FCC uncouples ATP production from oxygen consumption. Rotenone
and actimycin A inhibit mitochondrial respiration, allowing measurement of non-mitochondrial
respiration.
(D) Untreated or (E) LPS primed B6 and Card19-/- BMDMs were subjected to a mitochondrial
stress test, or Seahorse Assay. Oxygen consumption rate (OCR) was measured at baseline, after
injection of oligomycin, FCCP, and Rotenone/Actimycin A. Mean ± SEM of triplicate wells is
displayed. Representative of three independent experiments.
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Figure 2.11. CARD19 does not regulate Bax translocation during apoptosis
Cell lysates, TCA-precipicated supernatants and subcellular fractions were isolated from B6
(CARD19+) or Card19-/- (CARD19-) BMDMs following no treatment or two hours after Yp
infection or Sts treatment. Isolated fractions were assayed by western blotting for CARD19, Bax,
Bak, Cytochrome C, MAVS, Cytochrome C Oxidase Subunit IV (COX IV), Calnexin, HDAC1, and
Tubulin. Blots are representative of two independent experiments.
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Figure 2.12. CARD19 is not required for apoptotic or pyroptotic caspase cleavage and
activation
(A) B6, Card19-/-, Casp1/11-/- or Gsdmd-/- BMDMs were left untreated or infected with S. Tm, and
cell lysates (Lys) and TCA-precipitated supernatants (Sups) were run on SDS-PAGE and
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analyzed by western blotting for cleaved Casp1, GSDMD, or Actin (cell lysate loading control).
Cell death from these cells was assayed in parallel by LDH release (indicated below blots). Mean
± SEM is displayed. 2-way ANOVA with Bonferroni multiple comparisons post-test. *** p < 0.001,
** p < 0.01, * p < 0.05. n.d. not detectable.
(B) B6 (+) or Card19-/- (-) BMDMs were infected with Yp or treated with Sts or 2, 3, or 4 hours, or
left untreated (Un) as indicated. Cell lysates were prepared at indicated times and analyzed for
presence of CARD19, cleaved caspase-8, tBid, cleaved caspase-3, cleaved PARP, and Actin
(loading control).
(C) B6 and Card19-/- BMDMs were left untreated, infected with Yp or treated with staurosporine.
Lysates were harvested at the indicated time points, run on SDS-PAGE and analyzed by western
blotting for CARD19, GSDMD, GSDME/DFNA5, and actin (loading control).
(D) B6 (+) and Card19-/- (-) BMDMs were left untreated, treated with LPS, LPS+ATP, Sts, or
infected with S. Tm or Yp. Cell lysates (Lys) and supernatants (Sups) were harvested 1 hour
post-ATP or S.Tm infection or 3 hours post Sts treatment and Yp infection and assayed for
CARD19, Caspase-1, and presence of cleaved GSDMD.
(E) B6 and Card19-/- BMDMs were left untreated, infected with Yp, or treated with staurosporine.
BMDMs were pretreated with the caspase-8 inhibitor IETD for one hour prior to infection.
Caspase-8 activity was assessed by Caspase-8-Glo. Mean ± SEM is displayed. Blots, caspase-8
activity and LDH are representative of at least 3 independent experiments.
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Figure 2.13. CARD19 regulates release of intracellular alarmin HMGB1 following activation
of cell death
(A) Primary BMDMs from B6 (+) or Card19-/- (-) mice were treated with indicated treatments or
infections, and TCA precipitated supernatants (Sups) or whole cell lysates (Lysates) were
harvested at 1 or 4 hours post-infection and analyzed by western blotting for HMGB1, CARD19,
and actin (loading control). ATP indicates cells that were primed with LPS for 3 hours and treated
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with ATP for 1 or 4 hours. S.Tm – Salmonella Typhimurium; Yp Yersinia pseudotuberculosis. Sts
– staurosporine.
(B) Confocal microscopy images of untreated and staurosporine (Sts) treated B6 and Card19-/BMDMs fixed at indicated times post-Sts treatment and stained for HMGB1, Actin and DNA
(Hoescht). White arrows indicate HMGB1 clouds. Scale bar 20 microns, inset 10 microns.
(C) Quantification of nuclear HMGB1. n=25-50 cells per field, 5-8 fields per condition, per
timepoint.
(D) Quantification of HMGB1 clouds in B6 and Card19-/- BMDMs after staurosporine treatment. 58 fields quantified per condition, per timepoint. Mean ± SEM is displayed. *** p < 0.001, ** p <
0.01, * p < 0.05. n.s. not significant. 2-way ANOVA with Bonferroni multiple comparisons posttest. Representative of 3 (A-C) or 2 (D) independent experiments.
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Figure 2.14. CARD19 is not required for cytokine release
(A-E) B6 (black bars) and Card19-/- (red bars) BMDMs were primed with LPS for 3 hours and
treated with extracellular ATP, infected with S. Tm, Yp, or the Yp ΔEJK strain lacking effectors
YopE, YopJ and YopK. Supernatants were harvested 2 hours post-infection or ATP treatment
and analyzed by ELISA for release of (A) IL-1α, (B) IL-1B, (C) IL-6, (D) IL-12, and (E) TNF-α.
Mean ± SEM is displayed. Each figure is representative of 3 or more independent experiments.
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(F-H) B6 BMDMs were primed with LPS for 4 hours and infected with ΔoatA S. aureus or S. Tm.
(F) Lysates were harvested at indicated times, run on SDS-PAGE page and analyzed by western
blotting for Caspase 1, GSDMD, CARD19, or Actin (loading control). Supernatants were
harvested at indicated time points and analyzed by (G) LDH for cytotoxicity and (H) ELISA for
release of IL-1β. Each figure is representative of two independent experiments.
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Figure 2.15. CARD19 mediates anti-Yersinia host defense during oral infection
(A) Survival of B6 and Card19-/- mice following oral infection 108 CFUs of strain IP2777 Yp. Data
are pooled from two independent experiments that each gave similar results. Log-rank (MantelCox) Survival test.
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(B) Bacterial CFUs per gram tissue in Peyer’s Patches, MLN, Spleen and Liver in B6 and Card19/-

mice seven days post-oral infection with Yp. Representative of two (PP) or four (MLN, Spleen,

Liver) independent experiments. Unpaired Student’s t-test. ** p < 0.01, * p < 0.05.
(C) Representative images of naive and Yp-infected B6 and Card19-/- spleens, seven days postinfection Representative of three independent experiments.
(D) Quantification of naive and infected spleen weights. Data are pooled from three independent
experiments with similar results. Naive (n=5), Yp (B6 n=19, Card19-/- n=16) 2-way ANOVA with
Bonferroni multiple comparisons post-test. ** p < 0.01.
(E) Serum cytokines from naive and Yp infected B6 and Card19-/- mice. Data are pooled from four
independent experiments with similar results. Naïve (n=8), Yp (B6 n=31, Card19-/- n=28) 2-way
ANOVA with Bonferroni multiple comparisons post-test. * p < 0.05, n.s. not significant.
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CHAPTER 3: The pyroptotic executioner, gasdermin D, contributes to apoptosis in a
caspase-8 dependent manner
3.1. Introduction
Tschopp and colleagues coined the term “inflammasome” in their landmark 2002 study
describing a caspase-1/NLRP1/ASC activation complex (Martinon et al., 2002), but it took
another thirteen years before two independent labs identified gasdermin-D as the terminal target
of the inflammasome (Kayagaki et al., 2015; Shi et al., 2015a). Gasdermin D was hypothesized to
execute cells via pore formation, which was formally demonstrated by Lieberman and colleagues
shortly thereafter (Liu et al., 2016). Gasdermin E, also known as DFNA5, is cleaved by caspase-3
after treatment with chemotherapeutic agents (Wang et al., 2017) or cytochrome c (Rogers et al.,
2017) and forms lytic pores.
Gasdermin D and E are members of the gasdermin family, named thus by early reports of
expression in gastric and dermal tissues (Saeki et al., 2000; Tamura et al., 2007). The family was
originally identified as deafness associated tumor suppressors (DFNAs) when genetic mutations
were linked to non-syndromic deafness (Camp et al., 1995; Leon et al., 1992). Humans express
six gasdermins, gasdermin A through E and DFNB59 while mice have ten gasdermins,
gasdermin a1-3, gasdermin c1-4, gasdermin d, gasdermin e, and DFNB59 (Tamura et al., 2007).
Gasdermins have a bipartite domain structure with an N-terminal pore forming domain and a Cterminal inhibitory domain that prevents full-length gasdermins from forming pores prior to
activation (Ding et al., 2016; Shi et al., 2015b). Cleavage by caspases or proteases releases the
C-terminal end and allows the N-terminus to oligomerize and form pores, although the exact
event progression between cleavage and pore formation has not been determined. Furthermore,
a regulator of gasdermin events subsequent to processing has not been identified.
The mechanisms leading to cell death in the context of caspase-1 and -8 are believed to be
distinct. Therefore, how CARD19 promotes cell death downstream of both inflammatory and
apoptotic caspase activation is not clear. However, caspase-8 and caspase-1 can both cleave IL1β (Antonopoulos et al., 2013; Bossaller et al., 2012; Conos et al., 2016), indicating that these
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caspases share some degree of substrate specificity. Furthermore, caspase-8 compensates for
inhibition or loss of caspase-1 and gasdermin D (Mascarenhas et al., 2017; Pierini et al., 2012;
Sagulenko et al., 2013). Feng Shao and colleagues concluded that purified, recombinant
caspase-8 does not cleave gasdermin D when combined in vitro; however, these experiments
failed to properly activate caspase-8 prior to incubation with gasdermin D (Shi et al., 2015b). It is
well established that dimerization and auto-proteolysis is essential for the catalytic activity of
caspase-8 (Oberst et al., 2010). Therefore, it is unsurprising that inactive caspase-8 does not
cleave gasdermin D. Due to this experimental oversight, we cannot definitively conclude that
caspase-8 does not cleave gasdermin D.
In Chapter 2, we identified the mitochondrial protein, CARD19, as novel regulator of
caspase-dependent apoptosis and pyroptosis downstream of caspase activation and substrate
cleavage. Although CARD19 mediates death independently of IL-1 cytokine release, CARD19
does not mediate hyperactivation (Figure 2.14F). Indeed, we find that hyperactivation is
correlated with minimal gasdermin D cleavage relative to pyroptosis (Figure 2.14F). Since
CARD19-deficient macrophages do not have a defect in gasdermin D cleavage (Figure 2.12A, C,
D), this places CARD19 downstream of gasdermin cleavage. We additionally report that CARD19
regulates maximal PI uptake (Figure 2.5), suggesting it may influence gasdermin D pore
formation or stability. We therefore considered the possibility that gasdermin D cleavage, a
hallmark of pyroptosis downstream of caspase-1 and -11 activation, may also occur in the setting
of caspase-8 activation and may function as a common mechanism by which CARD19 mediates
cell death.
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3.2. Results
3.2.1.

Gasdermin D contributes to apoptosis in a caspase-8-dependent manner

We investigated whether gasdermin D contributed to apoptosis by infecting B6, Gsdmd-/-, and
Card19-/- BMDMs with Yp. Strikingly, Gsdmd-/- BMDMs exhibited a significant defect in cell death
in response to Yp infection, implicating gasdermin D in Yp-induced cell death (Figure 3.1A).
Since the defect in Gsdmd-/- BMDMs is not as pronounced as in Card19-/- BMDMs (Figure 3.1A),
CARD19 may additionally mediate gasdermin D-independent cell death, potentially through
gasdermin E/DFNA5 or other gasdermin family members (Figure 2.12C). Caspase-8 promotes
activation of caspase-1 in response to Yersinia infection (Philip et al., 2014; Weng et al., 2014),
raising the possibility that this is the basis for caspase-8-dependent gasdermin D cleavage.
However, we still detected cleaved gasdermin D in Casp1/casp11-/- lysates following either Yp
infection or staurosporine treatment (Figure 3.1B, C, red boxes). These findings are consistent
with recent reports that caspase-8 mediates gasdermin D cleavage during TAK1 inhibition and
Yersinia infection-induced apoptosis (Orning et al., 2018; Sarhan et al., 2018). Interestingly, the
levels of cleaved gasdermin D p30 were significantly lower in Casp1/casp11-/- cells than in Wt
cells (Figure 3.1B, C, red boxes), which suggests that caspase-1 contributes to gasdermin D
cleavage in the context of Yp-induced apoptosis. Critically, the caspase-8-selective inhibitor,
IETD, abrogated both gasdermin D and gasdermin E cleavage in response to Yp or staurosporine
in both B6 and Casp1/11-/- BMDMs (Figure 3.1B, C, blue boxes). The caspase-3,-7 inhibitor
DEVD, only marginally abrogated gasdermin D and E cleavage during apoptosis (Figure 3.1B, C,
green lanes), indicating that caspase-8 and caspase-1 are the primary activators of gasdermins
in response to these apoptotic stimuli. These data suggested that Yersinia and staurosporine
induce gasdermin D and E cleavage in Casp1/11-/- cells in a caspase-8-dependent manner.
Similarly, Ripk3-/- BMDMs showed robust cleavage of gasdermin D and E while Ripk3-/-Casp8-/BMDMs showed a near-complete absence of cleaved gasdermin D and E p30 following Yp
infection and significant reduction in gasdermin D and E p30 processing after staurosporine
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treatment (Figure 3.1B, C, brown boxes). Importantly, caspase-1 and gasdermin D were
processed equivalently in Ripk3-/- and Ripk3-/-Casp8-/- BMDMs in response to Salmonella infection
(Figure 3.1D, red and blue boxes), indicating that caspase-1 activity is not defective in Ripk3-/Casp8-/- BMDMs (Figure 3.1D, red box). The finding that gasdermin D cleavage occurs in the
setting of both caspase-1/11 and caspase-8 activation provides a mechanism for the shared role
of CARD19 in regulating cell death downstream of both pyroptotic and apoptotic caspases and
suggests that CARD19 acts at a terminal step downstream of both sets of pathways.
3.2.2.

Caspase-8 mediated cleavage of gasdermin D requires dimerization and catalytic
activity

To test whether caspase-8 is sufficient for gasdermin D cleavage and to define the
requirements for caspase-8-dependent gasdermin D cleavage, we co-expressed full-length
gasdermin D with chimeric caspase-8 proteins in which caspase-8 death-effector domains have
been replaced with the FKBP dimerizable domain, allowing for inducible dimerization in the
presence of AP20187 (Figure 3.2A) (Oberst et al., 2010; Pop et al., 2007). As expected from
prior reports (Shi et al., 2015a), caspase-8 expression was insufficient for robust activation of
gasdermin D, as measured by release of cleaved gasdermin D into the supernatant (Figure 3.2B
Lane 5, red box) or PI uptake (Figure 3.2C Image 5). However, caspase-8 activation requires
both homo-dimerization and auto-processing, as expression alone is insufficient for caspase-8
activation (Oberst et al., 2010). Indeed, release of cleaved gasdermin D into the supernatant and
PI uptake by cells required caspase-8 dimerization, auto-processing, and catalytic activity (Figure
3.2B, Lane 6, blue box), as neither catalytic (Figure 3.2B, Lane 10, green box) nor uncleavable
mutants (Figure 3.2B, Lane 14, brown box) could release cleaved gasdermin D into the
supernatant or mediate PI uptake upon dimerization (Figure 3.2C Image 10 and 14).
Furthermore, PI uptake by cells was negligible when caspase-8 was dimerized in the absence of
gasdermin D (Figure 3.2C Image 4), indicating that the release of cleaved gasdermin D into the
supernatant was not due to cleavage of other death-inducing targets by caspase-8.
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Interestingly, replacing the interdomain auto-processing site with TEV cleavage site led to
release of cleaved gasdermin D (Figure 3.2D, Lane 9, red box) and PI uptake (Figure 3.2E
Image 9) in response to dimerization alone, although TEV cleavage further increased cleaved
gasdermin D release (Figure 3.2D, Lane 11, blue box) and PI uptake (Figure 3.2E Image 11).
Unexpectedly, in the presence of caspase-8 we observed low levels of gasdermin D cleavage in
cell lysates even without caspase-8 activation (Figure 3.2B, Lane 5, grey box); however only
when caspase-8 activation was induced by dimerization did we observe significant PI uptake
(Figure 3.2C Image 6) and release of cleaved gasdermin D into the supernatant (Figure 3.2B,
Lane 6, blue box). Together these findings demonstrate that caspase-8 promotes gasdermin D
cleavage, and moreover, that this occurs not only in response to Yersinia infection (Orning et al.,
2018; Sarhan et al., 2018) but also in response to cellular stress induced by staurosporine.

3.3. Discussion
This study finds a role for gasdermin D in mediating apoptosis in addition to its well-defined
role in executing pyroptosis. We find that gasdermin D and gasdermin E are cleaved during Yp
and staurosporine induced apoptosis in a manner that depends on caspase-8. Interestingly,
Ripk3Casp3-/- macrophages retained some gasdermin D and E cleavage during staurosporine
treatment but not after Yp infection, suggesting that another caspase may be activated in the
absence of caspase-8 (Figure 3.1C). Additionally, caspase-8 mediated cleavage of gasdermin D
requires dimerization and catalytic activity, in accordance with our understanding of caspase-8
activity (Oberst et al., 2010). Between completion of these experiments described in Section 3.2.
and writing of this chapter, several reports were published that support these findings. Two
independent groups recently found that TAK1 inhibition by pharmacologic or microbial means
activated caspase-8 mediated gasdermin D cleavage (Orning et al., 2018; Sarhan et al., 2018).
Altogether, these data reveal that gasdermin D is an important mediator of apoptosis and identify
a potential mechanism by which CARD19 regulates apoptosis and pyroptosis in response to
multiple different stimuli. In Chapter 4, we examine potential interactions between CARD19 and
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gasdermin D and investigate whether CARD19 regulates terminal events of gasdermin family
mediated lysis.

3.4. Figures
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Figure 3.1. Caspase-8 mediates caspase-1-independent gasdermin cleavage
(A) B6, Card19-/-, and Gsdmd-/- BMDMs were infected with Yp and supernatants were assayed for
LDH release at indicated timepoints. Triplicate wells were harvested at the indicated time points.
2-way ANOVA with Bonferroni multiple comparisons post-test. *** p < 0.001. Representative of
two independent experiments.
(B, C) B6, Casp1/11-/-, Ripk3-/-, or Ripk3-/-/Casp8-/- BMDMs were left uninfected (Un), (B) infected
with Yp, or (C) treated with staurosporine (Sts) in the presence of DMSO, the caspase-3/7
inhibitor DEVD, and the caspase-8 inhibitor IETD. Lysates were harvested 3 hours post treatment
and analyzed by western blotting for GSDMD, DFNA5/GSDME, Caspase-8, Caspase-3 and actin
(loading control). Blots representative of three independent experiments.
(D) B6, Casp1/11-/-, Ripk3-/-, or Ripk3-/-/Casp8-/- BMDMs were left uninfected (-) or infected with S.
Tm. Lysates were harvested at 0.5 and 1 hr and analyzed by western blotting for Caspase-1,
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GSDMD, Caspase-8, and Actin (loading control). Blots representative of two independent
experiments.
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Figure 3.2. Caspase-8 mediated cleavage of gasdermin D requires dimerization and
catalytic activity
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(A) Domain structure for FBKP Caspase-8 constructs generated by Oberst and colleagues
(Oberst et al., 2010). Figure adapted from Oberst et al. JBC 2010.
(B, D) HEK293T cells were co-transfected with (C) wildtype caspase-8, catalytic mutant caspase8, or D5A uncleavable caspase-8, and full-length GSDMD or with (D) caspase-8-TEV, TEV, and
full-length GSDMD. Vector control was transfected such that each set of constructs received
equivalent amounts of DNA. Twenty-four hours after transfection, transfected cells were treated
with AP20187 (Dimerizer). Lysates were harvested 6 hours post-treatment and analyzed by
western blotting for GSDMD and Caspase-8. Numbers in parentheses on images in (C)
correspond to western blot lane number in (B). Blots representative of at least three independent
experiments.
(C, E) Representative widefield images of HEK293T cells transfected with (C) GSDMD and
wildtype caspase-8, catalytic mutant caspase-8, or D5A uncleavable caspase-8 or with (E)
GSDMD, caspase-8-TEV, and TEV protease. Conditions were normalized with vector to receive
the same amount of DNA. 24 hours post-transfection, dimerizer and PI were added. Numbers in
parentheses on images in (E) correspond to western blot lane number in (D). Wells were imaged
at indicated times.
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CHAPTER 4: CARD19 may promote the association of cleaved gasdermins with cellular
membranes
4.1. Introduction
The current model of gasdermin D activation identifies cleavage by caspases as the final step
prior to pore formation and places known regulators of pyroptosis upstream of gasdermin D
cleavage (Kayagaki et al., 2015; Liu et al., 2016; Sarhan et al., 2018; Shi et al., 2015a). However,
the existence of a regulatory step or checkpoint subsequent to cleavage and prior to terminal lysis
has been suggested on several occasions (DiPeso et al., 2017; Evavold et al., 2018). Release of
IL-1 by hyperactivated macrophages in response to S. aureus peptidoglycan genetically requires
gasdermin D (Evavold et al., 2018), implying that gasdermin D mediates non-lytic release of IL-1β
in this context and lytic death in others. In Chapter 2, we find that hyperactivated macrophages
release equivalent levels of IL-1β to pyroptotic macrophages, despite a dramatic reduction in
cleaved gasdermin D in lysates. These results suggest that hyperactivation may be regulated at
the step of gasdermin D cleavage, and that levels of gasdermin cleavage may be required to
surpass a certain threshold before lysis can occur. These data provide further evidence that a
regulatory step may exist post-cleavage, one that differentially promotes formation of an IL-1β
secreting/LDH-excluding gasdermin D pore in response to hyperactivating stimuli and a lytic pore
after pyroptotic stimuli.
Although the exact sequence of events during gasdermin pore formation following cleavage
is not known, several events downstream of gasdermin D pore formation have been identified.
Single cell based analysis revealed that prior to catastrophic loss of the cellular membrane, cells
undergo cell swelling, mitochondrial and lysosomal decay, nuclear rounding, and chromatin
condensation, as well as lose ion homeostasis and expose phosphatidylserine on the outer
membrane (de Vasconcelos et al., 2019). Furthermore, immortalized monocytes similarly swell,
lose mitochondria and cytoskeleton integrity, and release intracellular proteins during pyroptosis
(Davis et al., 2019). In many cases, these events occurred more than ten minutes before
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membrane permeability, suggesting terminal lysis results from a highly regulated, step-wise
dismantling of the cell following initial pore formation.
In Chapter 2, we identify CARD19 as a mitochondrial regulator of caspase-dependent
apoptosis and pyroptosis, downstream of caspase and gasdermin cleavage. Specifically, we find
that Card19-/- BMDMs have a defect in pore formation as measured by PI uptake (Figure 2.5),
but CARD19 is not required for gasdermin D or gasdermin E cleavage (Figure 2.12). These data
imply that CARD19 may facilitate the events required for gasdermin D/E-dependent lysis after
cleavage. In Chapter 3, we find that gasdermin D contributes to apoptosis in a caspase-8
dependent manner, a finding supported by several recent reports (Orning et al., 2018; Sarhan et
al., 2018). Thus, regulation of gasdermin pore formation or stability could be a common
mechanism by which CARD19 regulates apoptosis and pyroptosis in response to distinct stimuli.
In this chapter, we investigated the potential role of CARD19 in regulating the final steps between
gasdermin cleavage and terminal lysis.

4.2. Results
4.2.1. CARD19 may promote the association of cleaved gasdermins with cellular
membranes
In Chapter 2, we find that loss of Card19 results in a defect in pore formation as measured
by PI uptake in response to diverse stimuli (Figure 2.5). While CARD19 is not required for the
generation of mature gasdermin D or E (Figure 2.12), these results suggest CARD19 may
mediate gasdermin pore formation or stability. We therefore assessed the impact of CARD19 on
levels of cleaved gasdermins present in cytosolic, light membrane, and total membrane
subcellular fractions following exposure to caspase-activating stimuli. Intriguingly, Card19-/BMDMs infected with either S. Tm. or Yp had a small reduction in the amount of cleaved
gasdermin D in the light membrane fraction that contained the plasma membrane protein Na+/K+
ATPase but not the mitochondrial membrane protein COX IV (Figure 4.1A, red boxes).
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As CARD19-deficient cells are protected from lysis relative to wildtype cells under these
conditions, some fraction of wildtype cells may be lysing and release gasdermin D into the
supernatant, thereby reducing detectable levels of gasdermin D, particularly in the light
membrane fractions. We isolated subcellular fractions from cells treated in the presence of the
osmoprotectant glycine, which does not prevent formation of gasdermin D pores that are
permeable to PI or IL-1β, but protects the cells from lysis and LDH release (Evavold et al., 2018;
Heilig et al., 2017) (Figure 4.2).
Critically, we also observed a moderate reduction in cleaved gasdermin D in the light
membrane fraction of Yp- or S. Tm-infected cells in the presence of glycine, which suggests that
CARD19 might promote association of cleaved gasdermin D with cellular membranes even in the
absence of lysis (Figure 4.1B, red boxes). Intriguingly, glycine-treated B6 BMDMs also had
slightly increased association of cleaved gasdermin E with the light membrane fraction of Ypinfected cells relative to Card19-/- cells (Figure 4.1B, blue box), indicating a moderate effect of
CARD19 on recruitment or retention of gasdermins in light membrane fractions containing the
plasma membrane marker Na+/K+ ATPase subsequent to cleavage. Importantly, and consistent
with our earlier observations described in Chapter 2, levels of cleaved gasdermin D or E in whole
cell lysates were similar between B6 and Card19-/- BMDMs (Figure 4.1B, green boxes),
indicating that CARD19 does not regulate gasdermin processing. The gasdermin D N-terminus
specifically binds phospholipids in the inner leaflet of the plasma membrane, but also binds
cardiolipin, a major component of mitochondrial membranes (Liu et al., 2016). While we did
indeed detect cleaved gasdermin D in mitochondrial enriched fractions of BMDMs following Yp
infection or Sts treatment, mitochondrial-enriched fractions from CARD19-deficient cells did not
show lower levels of cleaved gasdermin D (Figure 4.1C, red box). Altogether, these data support
a potential model whereby CARD19 might regulate cell lysis by possibly promoting membrane
association of gasdermin D and E pores.
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4.2.2. Full-length Gasdermin D and E are partially associated with the cell periphery in
transfected cells
Since we find gasdermin D present in our mitochondrial fractions, we hypothesized that
CARD19 and gasdermin D might interact at plasma membrane associated membranes (PAMs)
which are dynamic sites of interaction between the plasma membrane and mitochondria and ERmembranes. Investigations into immunofluorescence (IF) was limited by gasdermin D antibodies
which are excellent for immunoblotting but not IF. We therefore utilized a well-established
transient expression system using HEK293T cells which have been previously used to
reconstitute many cell death and inflammasome pathways because they express very low or
undetectable levels of many key mediators including caspases.
When full length gasdermin D was transiently expressed, our data indicate that a portion
overlapped with the actin cortical network at the cell border (Figure 4.3-5). This preliminary
finding seems to contradict the current model of gasdermin activation in which full-length
gasdermins are located in the cytoplasm and held in an inactive confirmation by the C-terminus
(Figure 4.6). The N-terminus is liberated by cleavage which then oligomerizes and inserts into
the plasma membrane to form the pore. This model is based on assays that show recombinant
gasdermin D N-terminus binds to membranes made up of negatively charged phospholipids
including phosphatidylinositol phosphates (PIP) PtdIns(4)P, PtdIns(4,5)P2, and cardiolipin but not
to membranes consisting of phosphatidylethanolamine or phosphatidylcholine (Liu et al., 2016).
The full-length and C-terminus of GSDMD did not bind any of the tested lipids (Liu et al., 2016).
Lieberman and colleagues additionally transiently expressed an N-terminal FLAG tagged fulllength gasdermin D construct in HeLa cells which displayed diffuse cytoplasmic staining (Liu et
al., 2016). In contrast, we utilized an C-terminal FLAG tagged full-length gasdermin D (GSDMD
CT-FLAG) construct originally described by Vishva Dixit in HEK293T cells (Kayagaki et al., 2015),
and therefore investigated whether differences in the tag location or cell type could result in the
different localization phenotypes.
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To address the apparent discrepancy in localization between the two gasdermin D
constructs, we also acquired the N-terminal FLAG gasdermin D (NT-FLAG GSDMD) and
expressed both in HEK293T cells (Figure 4.3) and HeLa cells (Figure 4.4). To eliminate the
possibility that the FLAG tag itself was disrupting appropriate localization, we additionally
replaced the FLAG tag with an HA tag to generate GSDMD CT-HA and removed the FLAG tag
from NT-FLAG GSDMD, making untagged GSDMD (Figure 4.5). In HEK293T cells, GSDMD CTFLAG and GSDMD CT-HA partially localized at the cell periphery marked by actin, as did
untagged GSDMD. Given the current model that full-length gasdermin D is cytosolic, even a
minor association with the cell periphery by full length gasdermin D constructs is unexpected.
While NT-FLAG GSDMD somewhat overlapped with the actin network, it also stained more
cytoplasmically than the other constructs (Figure 4.3, 4.5). In HeLa cells, we found that full-length
gasdermin D constructs appeared to moderately localize at the cell periphery, although all four
constructs displayed more cytoplasmic distribution than in HEK293T cells (Figure 4.4, 4.5), which
is consistent with findings reported by Lieberman and colleagues (Liu et al., 2016).
We additionally examined the localization of the gasdermin D C-terminus. Interestingly, we
found that the gasdermin D C-terminus localized to the nucleus in HEK293T cells and both
nuclear and cytoplasmically in HeLa cells (Figure 4.7). This finding is particularly surprising given
than GSDMD-CT does not have a predicted NLS, although this may be an artifact of
overexpression. Altogether, these data reveal that gasdermin D may be localized at the cell
periphery under specific circumstances and poised for activation and pore formation.
We next considered whether this alternative localization may be a feature of the gasdermin
family and not unique to gasdermin D. After fractionation of BMDMs, we find the majority of fulllength gasdermin D and a significant portion of gasdermin E in membrane fractions (Figure
4.1B). We therefore obtained and ectopically expressed a C-terminal Myc and FLAG tagged
gasdermin E construct (Origene) in HEK293T and HeLa cells (Figure 4.8). Full-length gasdermin
E also partially localized at the cell periphery with actin in both cell types, suggesting that in some
cases gasdermins may be poised near the cell periphery (Figure 4.6). However, transient
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transfection of proteins can result in expression artifacts that do not reflect the true localization or
behavior of the endogenous protein. While both NT-FLAG GSDMD and GSDMD CT-FLAG have
been previously characterized (Kayagaki et al., 2015; Liu et al., 2016), our findings of gasdermin
D localization are unexpected, and therefore must be rigorously tested using multiple systems.
Currently, technical limitations have prevented visualization of endogenous gasdermin D in
BMDMs or other primary cells (data not shown). Until we can show that this localization occurs
in primary BMDMs or under endogenous expression levels, these results remain severely limited
in their generalizability.
Furthermore, while actin stains the cell periphery of HEK293T cells and HeLa cells, it is by no
means a true plasma membrane or cytoplasmic marker. To make any conclusions of whether fulllength gasdermin D associates with the plasma membrane prior to activation, we will need repeat
these experiments with multiple plasma membrane and cytosolic specific markers. Additionally,
the resolution at which the confocal microscopy images were generated do not allow us to
conclude that gasdermin D is associated or colocalized with the actin network or if it interacts with
the cytoskeleton. To make any such conclusions, we would need to perform experiments that
allow for superior resolution such as super resolution microscopy with deconvolution analysis
and/or electron microscopy. To investigate an interaction between full-length gasdermin D and
the plasma membrane or the cytoskeleton, we would need to perform experiments such as
pulldowns or FRET-based microscopy.
With these caveats in mind, our findings suggest a potential alternative explanation for
gasdermin activation, in which full-length gasdermins might be poised at the cell periphery by
peripheral membrane interactions prior to activation. In these specific circumstances, cleavage of
the inhibitory gasdermin C-terminus might facilitate integral membrane interactions and
subsequent pore formation. It is additionally possible that minor differences in gasdermin D
localization could serve as a potential contributor to kinetic differences in lysis in various cell
types. Altogether, these studies provide potential insight into the regulation of terminal cell lysis
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and might identify a novel role for the mitochondrial protein CARD19 in potentiating cell death
downstream of caspase and gasdermin D cleavage.
4.3. Discussion
Our data demonstrate that CARD19 may regulate distinct cell fate choices by potentially
promoting recruitment or stabilization of gasdermin D and E at the plasma membrane. We find
that while CARD19 was not required for generation of the cleaved gasdermin D or E-NT
fragments (Figure 2.12), Card19-/- BMDMs had slightly lower levels of cleaved gasdermin D and
E present in the light membrane fractions (Figure 4.1). Furthermore, we showed in Chapter 2
that Card19-/- BMDMs exhibited lower levels of pore formation as measured by PI uptake (Figure
2.5) and released less full-length and cleaved GSDMD into the supernatant (Figure 2.12). These
results potentially implicate CARD19 as the first regulator of gasdermin D and E activity postcleavage, however, however additional experiments will be required for further understand the
contribution of CARD19 to terminal events in cell death pathways.
Examination of full-length gasdermin D and E during transient transfection in HEK293T and
HeLa cells revealed the surprising finding that gasdermin D and E partially localized at the cell
periphery and somewhat overlapped with the cortical actin network (Figures 4.3-5, 4.8). These
findings were particularly surprising in light of the current model for inactive gasdermin D
localization to the cytoplasm prior to cleavage (Liu et al., 2016) (Figure 4.6). Full-length
gasdermin D was shown to localize to the cytoplasm by immunofluorescence in HeLa cells (Liu et
al., 2016). Interestingly, we found that multiple full-length gasdermin D constructs partially
localized at the cell periphery in HEK293T and HeLa cells following transient transfection (Figure
4.3, 4.4). Future studies will rigorously examine the localization of full-length gasdermin D by
utilizing plasma membrane and cytoplasmic specific markers. We will additionally assess the
distribution of gasdermins within the cell following treatment with actin or microtubule
depolymerizing agents. We additionally showed that overexpression of the C-terminus of
gasdermin D resulted in nuclear localization, suggesting the possibility that gasdermin D may play
additional roles in the nucleus (Figure 4.7).
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Interpretation of these findings are strongly limited since transient overexpression system we
are utilizing may not reflect the true localization and behavior of endogenous gasdermin D and E.
Although we see a small amount of overlap of full-length gasdermins with the cell periphery, we
cannot make definitive conclusions about whether full-length gasdermins are actually associated
or interacting with the plasma membrane. Furthermore, the immortalized nature of HEK293T and
HeLa cells may impact the behavior and localization of transfected gasdermins compared to
endogenous protein in primary BMDMs. It remains to be seen whether our observations are
biologically meaningful in any way. Future investigations will examine gasdermin D and E
localization following transduction or electroporation of gasdermins into primary gsdmd-/- and
gsdme-/- BMDMs and continue testing reagents to visualize endogenous gasdermins in primary
cells.
Keeping the limitations of these experiments in mind, our results provide us with the
opportunity to speculate about a potential interaction between CARD19 and gasdermins at sites
of interaction between mitochondria and plasma membranes which are known as PAMs. PAMs
are sites of interactions between the plasma membrane and other membranes, predominantly
comprised of mitochondria and ER (Szymański et al., 2017). PAMs are thought to be highly
dynamic regions that regulate lipid and calcium homeostasis. Up to 10% of the plasma
membrane is in contact with mitochondria and loss in these contact points substantially alters
calcium homeostasis (Frieden et al., 2005). Future experiments will investigate whether CARD19
and gasdermin D are associated with PAMs and if CARD19 perturbs either calcium or lipid
homeostasis as a means of potentiating cell death.
Alternatively, it is possible that gasdermins might localize to mitochondria or in close
proximity of mitochondrial membranes. We find that cleaved gasdermin D is present in
mitochondria-enriched fractions, although we cannot definitively conclude gasdermin D is located
at mitochondria in BMDMs since we also see contamination of mitochondria fractions by a
plasma membrane marker. Additionally, cleaved gasdermin D was found to bind to cardiolipin, a
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major component of mitochondrial membranes (Liu et al., 2016). Future investigations will
examine whether gasdermins localize at or near mitochondria.
It is also possible that CARD19 mediates cell death through a separate mechanism. Since
CARD19 contains a protein-protein interacting CARD, CARD19 might interact with another CARD
protein to promote lysis. MAVS, the only other CARD protein with a transmembrane domain, is
also localized to mitochondria and peroxisomes. Although we did not find a role for MAVS in
CARD19-mediated cell death (Figure 2.7), CARD19 could interact with another CARD-containing
protein. Future experiments were investigate this potential mechanism by performing CARD19
pulldowns and probing for other known CARD proteins.
Altogether these data provide an intriguing potential mechanism by which CARD19 mediates
cell death. Here we show that CARD19 might promote the association of cleaved gasdermins
with cellular membranes. The observed phenotype is much weaker than we might expect given
the strength of the defect in cell death in the Card19-/- BMDMs. This suggests that CARD19 might
be acting in an alternative manner to promote the progression to terminal apoptosis and
pyroptosis and that minor differences in gasdermin association with membranes might be the
result of this unidentified mechanism.
Our preliminary findings that full length gasdermin D and E are in close proximity to the actin
cortical network and cell periphery following transient transfection suggest a possible alternative
explanation for the activation of gasdermins during cell death. In this proposed model, full-length
gasdermin D and E may be in close proximity to or associated with the plasma membrane,
potentially poised to form pores following cleavage by caspases (Figure 4.6). Currently, technical
limitations with gasdermin antibodies have prevented immunofluorescence in primary cells.
However, with new antibodies developed regularly, it will be essential to examine endogenous
gasdermin localization in primary BMDMs. In summary, our data reveal a novel function for
CARD19 in the regulation of caspase-dependent cell death and suggest a possible model in
which CARD19 might contribute to cell death by potentially promoting recruitment or retention of
cleaved gasdermins to cellular membranes.
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4.4. Figures
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Figure 4.1. CARD19 may promote the membrane association of cleaved gasdermins
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(A) Western blots from B6 and Card19-/- BMDMs separated into cytoplasmic, light membrane, and
total membrane fractions. Fractions from untreated, Yp, and S. Tm infected BMDMs were probed
for gasdermin D, Na+/K+ ATPase (light membrane control), tubulin (cytoplasmic control), and
COX IV (total membrane control).
(B) Western blots from B6 and Card19-/- BMDMs separated into cytoplasmic, light membrane,
total membrane fractions and whole cell lysates. Fractions from untreated, Yp and S. Tm infected
BMDMs treated with the osmoprotectant glycine were probed for gasdermin D, gasdermin
E/DFNA5, CARD19, Tubulin, COX IV, and Na+/K+ ATPase. Blots are representative of two or
three independent experiments.
(C) Membrane Fractionation Scheme. 5-6.5*107 BMDMs were infected with either Yp or S. Tm
(MOI 10) for the indicated times, in the presence or absence of glycine. Cells were harvested in
cold PBS, resuspended in homogenization buffer (HB) plus protease inhibitors and homogenized
using a Potter-Elvenhjem homogenizer at 4000 RPM until 75-80% of cells were disrupted. Debris
was spun out at 700g for 10 minutes. The supernatant (S0.7) was spun at 10,000g for 30 min.
The supernatant (S10) was the cytoplasmic fraction. The pellet (P10) underwent phase extraction
using Abcam’s Plasma Membrane Extraction Kit according to the manufacturer’s instructions.
Following phase extraction, the combined upper phases were spun at 20,000g for 1 hour. The
upper phase pellet (upP20) was resuspended in Mitochondrial Extraction Buffer (see below) as
the light membrane fraction. The supernatant (upS20) was combined with the combined lower
phases from the phase extraction and spun at 20,000g for 1 hour. The lower phase pellet (lpP20)
was resuspended in Mitochondrial Extraction Buffer as the total membrane fraction. All fractions
were normalized to 1 mg/mL with appropriate buffers and 1x sample buffer using a Nanodrop. All
cells were conducted at 4°C and all buffers contained protease inhibitors unless otherwise noted.
(D) Western blots from B6 and Card19-/- BMDMs separated into nuclear, mitochondria and
cytoplasmic enriched fractions. Fractions from untreated, Yp, and Sts treated BMDMs were
probed for CARD19, MAVS, COX IV (mitochondria loading control), GSDMD, Na+/K+ ATPase,
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HDAC1 (nuclear control), and tubulin (cytoplasmic control). Representative of two independent
experiments.
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Figure 4.2. Glycine reduces cell death in B6 and Card19-/- BMDMs
(A-D) B6 or Card19-/- BMDMs were treated with (A) S. Tm (B) LPS+ATP, (C) Yp, or (D)
staurosporine (Sts) with or without glycine, and cell death was assayed by LDH release. Mean ±
SEM of triplicate wells is displayed. Each figure is representative of 2-4 independent experiments.
*** p < 0.001, ** p < 0.01, * p < 0.05. n.s. not significant. 2-way ANOVA with Bonferroni multiple
comparisons post-test.
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Figure 4.3. Ectopically expressed full-length gasdermin D partially localizes to the cell
periphery in HEK293T cells
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HEK293T cells were transfected with GSDMD CT-FLAG, GSDMD CT-HA, NT-FLAG GSDMD,
and Untagged GSDMD. Cells were fixed 24 hours post transfection, stained for anti-FLAG, antiHA, or anti-GSDMD, and for actin (Phalloidin) and DNA (Hoechst). Cells were imaged at 1x and
2.5x zoom. Scale bar 50 microns (1x), or 20 microns (2.5x). Inset scale bar 5 microns.
Representative of three or more independent experiments.
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Figure 4.4. Ectopically expressed full-length gasdermin D partially localizes to the cell
periphery in HeLa cells
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HeLa cells were transfected with GSDMD CT-FLAG, GSDMD CT-HA, NT-FLAG GSDMD, and
Untagged GSDMD. Cells were fixed 24 hours post transfection, stained for anti-FLAG, anti-HA, or
anti-GSDMD, and for actin (Phalloidin) and DNA (Hoechst). Cells were imaged at 1x and 2.5x
zoom. Scale bar 50 microns (1x), or 20 microns (2.5x). Inset scale bar 5 microns. Representative
of three or more independent experiments.
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Figure 4.5. Gasdermin D partially overlaps with actin cortical network in HEK293T and
HeLa cells
(A) Domain structure of the gasdermin D constructs utilized. NT, N-terminus, CT, C-terminus.
(B) Quantification of images presented in Figure 4.3, 4.4. Fields of view containing 20-50 cells
were quantified for total gasdermin D staining and the percentage of gasdermin D colocalizing
with actin. Each graphed dot represents a single field of view. FOV from 2 (Untagged GSDMD), 3
(GSDMD CT-HA and NT-FLAG GSDMD), or 5 (GSDMD CT-FLAG) independent experiments
were pooled (3-8 FOV per experiment).
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Figure 4.6. Current and proposed models for gasdermin activation
(A) The current model of gasdermin D and E activation. Full-length gasdermin D and E are
localized in the cytoplasm, held inactive by the C-terminus. Caspase-1, -8, or -3 cleave
gasdermin D and E, respectively, allowing the N-terminus to oligomerize, insert into the plasma
membrane, and form a pore that potentiates IL-1β release and lysis.
(B) The proposed model of gasdermin D and E activation. Full-length gasdermin D and E may be
partially associated with or in close proximity to the plasma membrane at steady state, in an
inactive confirmation by the C-terminus. Caspase-1, -8, or -3 cleave gasdermin D and E,
respectively, allowing the N-terminus to oligomerize, insert into the plasma membrane, and form
a pore that potentiates IL-1β release and lysis. Differences in association with the membrane may
explain kinetic differences in gasdermin D/E dependent pyroptotic and apoptotic death in different
cell types.
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Figure 4.7. The C-terminus of gasdermin D localizes to the nucleus
(A) Domain structure of the C-terminus gasdermin D constructs utilized. CT, C-terminus.
(B) Confocal microscopy images of HEK293T and HeLa cells transfected with CT GSDMD CTFLAG or CT NT-FLAG GSDMD. Cells were fixed 24 hours post transfection and stained with antiFLAG (green), and for DNA (blue, Hoechst). Scale bar 50 microns, inset scale bar 5 microns.
Representative of 3 or more independent experiments.
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Figure 4.8. Gasdermin E partially overlaps with the actin cortical network in HEK29T and
HeLa cells
(A) Domain structure of the gasdermin E construct utilized. NT, N-terminus, CT, C-terminus.
(B) Confocal microscopy images of HEK293T and HeLa cells transfected with GSDME-FLAG.
Cells were fixed 24 hours post transfection and stained with anti-FLAG (green), and for actin (red,
Phalloidin) and DNA (blue, Hoechst). Scale bar 50 microns (1x) or 20 microns (2.5x), inset scale
bar 5 microns.
(C) Quantification of GSDME-FLAG staining overlapping actin from (B). Each dot is a single field
of view containing 20-50 cells. Fields from two independent experiments were pooled.
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CHAPTER 5: Discussion and Future Directions
5.1. Summary of findings
Regulated cell death (RCD) is an essential mechanism by which the innate immune system
defends against microbial invaders. Caspase activation and recruitment domain (CARD) proteins
and related death domain superfamily members are key mediators of cell death, gene
expression, and intracellular signaling pathways. In our quest to understand how cell death is
regulated in response to bacterial infection, we identified CARD19 as a potential mediator of
RCD. In this study, we hypothesized that CARD19 may play a role in RCD pathways in response
to bacterial infection or innate immune signaling. In Chapter 2, we identify CARD19 as a
mitochondrial regulator of caspase-dependent apoptosis and pyroptosis in response to a variety
of microbial and chemical stimuli. Furthermore, CARD19 mediates apoptosis and pyroptosis
independently of IL-1 cytokine release, genetically uncoupling pyroptotic cell death and IL-1
release for the first time. We additionally show that CARD19 mediates in vivo anti-Yersinia host
defense following oral infection.
In Chapter 3, we used a combination of genetic models and inhibitors to show that the
pyroptotic executioner, gasdermin D, is cleaved and activated during apoptosis in a caspase-1independent, caspase-8-dependent manner. We find that gasdermin D-mediated pore formation
and subsequent PI uptake requires caspase-8 dimerization and catalytic activity, which is
consistent with our understanding of caspase-8 activity (Oberst et al., 2010).
In Chapter 4, we investigated the mechanisms by which CARD19 mediates apoptosis and
pyroptosis. We biochemically fractionated BMDMs and find that CARD19 might promote the
association of cleaved gasdermin D and E with cellular membranes. This finding was intriguing
and somewhat surprising, since we have not detected CARD19 outside of either the ER or
mitochondria. We investigated whether CARD19 and gasdermin D were localized to the same
cellular space, and our data indicate that full-length gasdermin D and E partially overlap with the
actin cortical network and cell periphery in transient transfection systems employing either
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HEK293T or HeLa cells. These results might suggest that in some cases, gasdermins might be
poised at the membrane to form pores upon activation, potentially analogous to the “pre-pore”
formed by diverse pore-forming toxins of bacterial pathogens (Heuck et al., 2000; Hotze et al.,
2001; Soltani et al., 2007). Furthermore, our data indicate that the C-terminus of gasdermin D
partially localizes to the nucleus following transient transfection in HEK293T or HeLa cells. These
data implicate CARD19 as an important regulator of cell death and innate immunity and
contribute to our collective understanding of the mechanisms governing cell death.

5.2. Key findings
5.2.1.

CARD19 is a mitochondrial regulator of apoptosis and pyroptosis

The innate immune system tightly coordinates activation of regulated cell death pathways in
response to insult, injury, and infection. Numerous mediators have been identified and
characterized; however, our understanding of RCD mechanisms still contains significant gaps.
For example, when we began our investigation, hyperactivation was a controversial topic. In
recent years, multiple reports have identified numerous instances in which IL-1 release is
separable from lytic death (Chen et al., 2014; DiPeso et al., 2017; Evavold et al., 2018; Gaidt et
al., 2016; Gaidt and Hornung, 2017; Zanoni et al., 2016; Zanoni et al., 2017). Nonetheless, we
still do not understand how and when cells commit to hyperactivation versus terminal lysis or
which proteins or complexes are involved in that decision. Additionally, the extent to which cell
death pathways crosstalk during infection and injury remains to be elucidated. We do not know
whether a single cell simultaneously activates multiple death pathways or if heterogeneity within a
population results from each cell activating different but singular pathways. There are numerous
examples of apoptosis being activated after pyroptotic proteins are pharmacologically or
microbially inhibited and vice versa (Antonopoulos et al., 2013; Mascarenhas et al., 2017; Pierini
et al., 2012; Taabazuing et al., 2017), but it is not clear whether cell death crosstalk is a hallmark
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of these pathways or whether it evolved as a contingency. Lastly, we do not fully understand the
dynamic regulation, coactivation, and cross-talk between various death pathways in vivo.
In this study, we sought to identify and characterize additional contributors to innate immunity
and cell death. Fortuitously, we identified CARD19, also known as BinCARD, as a novel regulator
of RCD. In Chapter 2, we found that CARD19 was required for maximal caspase-dependent
apoptosis and pyroptosis as measured by LDH release and PI uptake (Figure 2.5, 2.6, 2.8).
Although CARD19 did not contribute to lytic death during programmed necrosis, Card19-/BMDMs displayed a moderate delay in PI uptake during LPS and zVAD treatment (Figure 2.6F),
suggesting a general role for CARD19 in regulating membrane integrity or repair.
Identification of CARD19 as a dual regulator of pyroptosis and apoptosis was an unexpected
but intriguing finding, particularly given the strength of the defect in cell death in response to
multiple apoptotic and pyroptotic stimuli. Apoptosis and pyroptosis were previously thought to be
distinctly regulated, in part because BMDMs lacking essential apoptosis regulators such as
caspase-8 do not have significant defects in pyroptotic lysis (Man et al., 2013). Similarly,
casp1/casp11-/- BMDMs undergo wildtype levels of apoptosis in response to Yersinia (Orning et
al., 2018; Philip et al., 2014). However, our data suggest that apoptosis and pyroptosis may be
dynamically co-regulated in response to certain stimuli. In the case of microbial infections like Yp
and S. Tm which are capable of activating multiple cell death pathways (Antonopoulos et al.,
2015; Philip et al., 2014), it is possible that CARD19 modulates cellular responses based on the
intensity or type of initiating stimuli.
In addition to their vital role in metabolism, ATP production, and homeostasis, mitochondria
serve as scaffolds for signaling complexes during infection (Liu et al., 2013; Seth et al., 2005;
Subramanian et al., 2013). CARD19 is one of two CARD proteins with a transmembrane domain
and structurally resembles the other, MAVS (Figure 2.1A) (Dixit et al., 2010; Seth et al., 2005). In
addition to its well-defined role in assembling a signaling complex at mitochondria in response to
viral nucleic acids (Liu et al., 2013; Seth et al., 2005), MAVS also anchors the NLRP3
inflammasome at mitochondria after nigericin treatment, amplifying pyroptotic responses
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(Subramanian et al., 2013). We therefore examined the cellular location of CARD19 in primary
BMDMs. Consistent with previous overexpression reports (Chen et al., 2013), we found that
endogenous CARD19 localized to mitochondria and overlapped significantly with MAVS in
BMDMs (Figure 2.1-4). Despite similar localization and domain structure, we did not find a role
for MAVS in CARD19-potentiated cell death (Figure 2.7). Since mitochondria act as key
mediators of cell death, we investigated whether CARD19 perturbed mitochondrial homeostasis
or recruitment of pore-forming proteins to mitochondria. Surprisingly, loss of Card19 did not
impact basal or stimulation-induced oxidative phosphorylation in primary BMDMs (Figure 2.10),
nor did it impair recruitment of the pore forming protein Bax to mitochondria (Figure 2.11, red
boxes).
Although these results suggest CARD19 may not mediate cell death by altering or impairing
mitochondrial function, we have not exhaustively investigated the role of CARD19 at
mitochondria. Mitochondria ROS production (Banki et al., 1999), loss of mitochondrial membrane
potential (Heiskanen et al., 1999; Waterhouse et al., 2001), disruption of ion homeostasis (AbuHamad et al., 2009; Yaron et al., 2015), and release of pro-death proteins from the mitochondria
(Du et al., 2000; Li et al., 1997) are important events regulated by death domain superfamily
members that can occur during apoptosis and pyroptosis, depending on the initiating stimuli.
CARD19 could potentially be involved in these events as a means of promoting cell death.
5.2.2.

CARD19 regulates terminal events during cell death independently of cytokine
release

As a regulator of two distinct death pathways, we hypothesized that CARD19 mediated
caspase cleavage or activation; however, CARD19 was not required for either caspase cleavage
or subsequent activation, as measured by the cleavage of specific caspase substrates (Figure
2.12A green boxes, 2.12B blue and brown boxes, 2.12C red and blue boxes, 2.12D green
box). This finding was surprising given the lack of apparent overlap between essential mediators
during apoptosis and pyroptosis and imply that apoptosis and pyroptosis may be fundamentally

103

intertwined. These data suggest that either CARD19 potentiates apoptosis and pyroptosis by
different mechanisms, or that the decision to commit to either apoptosis or pyroptosis is made
prior to the contribution of CARD19. It also begs the question as to where a cell commits to a
particular pathway and whether that decision retains plasticity. In other words, where is the point
of no return during RCD and does CARD19 play a role in that decision? Ultimately these results
suggest that CARD19 potentiates cell death downstream or parallel to caspase and substrate
cleavage.
We next investigated whether CARD19 regulated terminal events during cell death such as
the release of alarmins and inflammatory cytokines. Card19-/- BMDMs exhibited a significant
defect in HMGB1 release during apoptosis and pyroptosis relative to B6 cells (Figure 2.13, red
and blue boxes, - lanes). Unexpectedly, CARD19 did not regulate IL-1 or canonical NFκBdependent cytokine release (Figure 2.14). Prior to our investigations, well-established models
spatially and temporally linked IL-1 release and immunogenic cell death (Martinon et al., 2002).
However, during our investigations, reports from multiple groups identified instances where cells
cleave and activate terminal caspases and release IL-1 without apparent lysis, a state termed
“hyperactivation” (Chen et al., 2014; Evavold et al., 2018; Gaidt and Hornung, 2017; Zanoni et al.,
2016). Since Card19-/- cells release IL-1 but have a significant delay in lysis, we hypothesized that
CARD19 might regulate hyperactivation. Interestingly, CARD19 was not required for
hyperactivation, but substantially reduced gasdermin D cleavage was associated with
hyperactivation conditions (Figure 2.14F, red box), suggesting that hyperactivation might be
regulated at the level of gasdermin D cleavage. These results indicate that CARD19 acts
downstream of hyperactivation, as Card19-/- BMDMs do not have a defect in gasdermin D
cleavage.
Our results provoke the question as to how cells specifically regulate the release of certain
lytic markers while retaining others. For example, Card19-/- BMDMs become permeable to PI
concomitantly as B6 macrophages, however, the magnitude of membrane permeability is much
lower. Price and colleagues found that uptake of membrane integrity markers tracked with the
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size of the dye, with smaller dyes such as Sytox Blue (0.4 kD) were taken up earlier than larger
dyes like ethidium bromide (0.85 kD) (DiPeso et al., 2017). Furthermore, release of larger
proteins such as LDH (36 kD) did not occur until later. These results support the model that early
pre-lytic gasdermin pores are sufficiently large to release small molecules such as IL-1 and ATP
but small enough to exclude larger proteins (Russo et al., 2016). Subsequently, as of yet
unidentified mediators or signals promote the formation of larger gasdermin pores which facilitate
terminal lysis.
Alternatively, kinetics of organelle permeability could play a role in release. For instance, the
nuclear membrane must also be permeabilized for HMGB1 release from cells while only the
plasma membrane has to be permeabilized for IL-1 release. However, protein release based on
pore size or permeability kinetics fail to explain why the p20 cleavage product of caspase 1
remains in the lysates of Card19-/- BMDMs (Figure 2.12D, red box) at time points in which we
see PI uptake (Figure 2.5). These findings contradict the current model that the gasdermin D
pore is a non-selective channel (Chen et al., 2016) and suggest that protein release is regulated
in some way. Whether that discrimination is performed by the pore itself remains to be seen.
Additional studies are required to identify what underlies the release of some proteins but not
others by gasdermin pores prior to lysis.
5.2.3.

CARD19 mediates anti-Yersinia host defense

Cell death is an essential component of antibacterial defenses during in vivo infections. In
murine models of infection, mice lacking key mediators of apoptosis and pyroptosis exhibit acute
susceptibility to bacterial infections (Lara-Tejero et al., 2006; Man et al., 2017a; Peterson et al.,
2017; Philip et al., 2014; Pierini et al., 2012). Consistent with these findings, CARD19 deficiency
resulted in enhanced susceptibility to oral Yersinia pseudotuberculosis infections in mice. Card19/-

mice displayed increased mortality, splenomegaly, systemic Yp tissue burdens, and serum

cytokines relative to wildtype controls (Figure 2.15). Together, these data support a role for
CARD19 in mediating anti-Yersinia host defense. Since CARD19 does not contribute to cytokine
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production in response to Yp in vitro, it is likely that CARD19 mediates cell-intrinsic death as a
mechanism for anti-Yersinia control, although this remains to be formally tested. Future studies
will examine whether CARD19 mediates antimicrobial responses to other pathogens that require
caspase-dependent pathways for control such as Salmonella Typhimurium and Toxoplasma
gondii.
During immunogenic cell death in vivo, it is often difficult to separate the individual
contributions of cell death and IL-1 cytokine release. Mice deficient for IL-1 family members or
receptors are useful tools for investigating the contribution of IL-1 cytokines to antimicrobial host
defense in vivo (Labow et al., 1997; Raupach et al., 2006). Examination of the contribution of cell
death in vivo independently of cytokine production has been much more challenging. Since
CARD19 is not required for inflammatory IL-1 cytokine production during apoptosis and
pyroptosis either in vitro or in vivo, Card19-/- mice can serve as a useful genetic tool to investigate
the in vivo contribution of cell death independently from inflammatory cytokine production.
5.2.4.

Gasdermin D contributes to apoptosis in a caspase-8-dependent manner

The pyroptotic executioner gasdermin D was recently identified as the terminal cleavage
target of caspase-1 during pyroptosis (Kayagaki et al., 2015; Liu et al., 2016; Shi et al., 2015a). In
Chapter 2 we showed that CARD19 mediates apoptosis and pyroptosis downstream of caspase
cleavage. We therefore hypothesized that CARD19-mediated gasdermin D pore formation could
be a mechanism by which CARD19 regulates two distinct pathways. In Chapter 3, we found that
gasdermin D contributed to apoptosis in response to Yp and was cleaved in a caspase-8
dependent manner following treatment with staurosporine or Yp infection (Figure 3.1). We
utilized a caspase-8 forcible dimerization model to investigate the domain requirements for
caspase-8 mediated cleavage of gasdermin-D. In agreement with previous caspase-8
investigations (Oberst et al., 2010), we found that cleavage of gasdermin D required dimerization
and catalytic activity of caspase-8 (Figure 3.2, 3.3). These findings are supported by very recent
studies identifying a role for gasdermin D in apoptosis induced by TAK1 inhibition (Orning et al.,
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2018; Sarhan et al., 2018) which mimics the NFκB and MAPK blockade by Yersinia effector
proteins that induce caspase-8-dependent apoptosis. Interestingly, Lien et al. found that caspase8 was the predominate driver of gasdermin D cleavage in response to Y. pestis and TAK1
inhibition with minor contributions from caspase-1 (Orning et al., 2018). In contrast, we find a
substantial reduction in gasdermin D cleavage in casp1casp11-/- BMDMs during Y.
pseudotuberculosis and staurosporine treatment, indicating that caspase-1 is a significant
contributor to gasdermin D cleavage in this context. This apparent discrepancy could result from
the usage of different Yersinia strains and inhibitors and indicates that the contribution of
caspase-1 in gasdermin D-mediated apoptosis may be dynamically regulated.
Interestingly, when gasdermin D was transfected in the presence of caspase-8 in the
absence of the dimerizing agent, we saw a small amount of cleaved gasdermin D present in cell
lysates without overt cytotoxicity or PI uptake (Figure 3.2B Lane 5, grey box, 3.2C Image 5).
This cleavage could result from residual activity of full-length caspase-8 or low levels of
endogenous caspases present within HEK293T cells. Regardless of the source of cleavage, the
presence of mature gasdermin D without PI uptake provides additional support for the model of a
pre-lytic gasdermin pore that must surpass as threshold or checkpoint prior to lysis (Russo et al.,
2016), and that additional regulatory steps facilitate pore formation subsequent to gasdermin
cleavage. As a whole, our studies described here and related published reports reveal a
previously unappreciated role for gasdermin D during apoptosis and suggest a common
mechanism by which CARD19 regulates apoptosis and pyroptosis in response to diverse stimuli.
5.2.5.

CARD19 may promote the association of cleaved gasdermins with cellular
membranes

We demonstrated in Chapter 2 that CARD19 is not required for gasdermin D or E cleavage
during apoptosis and pyroptosis (Figure 2.12A green boxes, 2.12C red and blue boxes).
However, we also found that CARD19 is required for maximal pore formation, as measured by PI
uptake (Figure 2.5), suggesting that CARD19 may regulate events between gasdermin cleavage
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and terminal lysis. To date, no regulator has been identified that acts on gasdermin D or E
following cleavage. We investigated whether CARD19 mediated pore formation by biochemically
fractionating BMDMs into cytosolic, light membrane, and total membrane fractions. We found a
small but reproducible defect in the amount of cleaved gasdermin D and E localized to Card19-/light membrane fractions that also contained the plasma membrane protein Na+/K+ ATPase
during Yp and S. Tm infection relative to B6 cells (Figure 4.1, red and blue boxes). Although we
did not find CARD19 in the light membrane fraction, additional fractionation experiments revealed
that cleaved gasdermin D might be present in mitochondria-enriched fractions (Figure 4.1C, red
box). Furthermore, gasdermin D was shown to bind to a cardiolipin, a major component of
mitochondrial membranes (Liu et al., 2016). Additional experiments are required to investigate
whether gasdermins localize to mitochondria and if so, to the same mitochondrial microdomains
as CARD19. If gasdermins bind to mitochondria membranes, they might contribute to
catastrophic mitochondrial membrane permeabilization and release of cytochrome c which
promotes apoptosome formation and terminal lysis. This could be tested by incubating
recombinant gasdermins with purified mitochondria and testing for cytochrome c release.
Alternatively, the mitochondria could act as a sink for cleaved gasdermins and slow the formation
of lytic pores at the plasma membrane.
Given the magnitude of the difference in LDH release between wildtype and Card19-/BMDMs undergoing cell death, the subtle difference in cleaved gasdermins in light membrane
fractions suggest that CARD19 may be acting by alternative or additional mechanisms. It is
possible that CARD19 acts on mitochondria to promote terminal lysis by promoting formation of
mitochondrial pores, facilitating ROS production, inducing loss of mitochondrial membrane
potential or destabilizing homeostatic signaling required for survival. Alternatively, CARD19 could
interact with another CARD protein to facilitate lysis. While MAVS originally appeared to be an
attractive candidate, we did not find a role for MAVS in CARD19-mediated cell death. However,
there may be additional candidates for CARD19 interactions.
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One potential protein is NLRX1, a member of the NLR sensor family that localizes to
mitochondria outer membranes and inhibits MAVS-mediated anti-viral signaling (Halle et al.,
2008). NRLX1 is also involved in innate immune responses to bacterial pathogens such as H.
pylori (Philipson et al., 2015) and during gut inflammation (Leber et al., 2018). While most
interactions between death domain superfamily members are homotypic (i.e. CARDs interact with
other CARDs), NRLX1 heterotypically interacts with MAVS via its NBD domain (Halle et al.,
2008). This provokes the intriguing possibility that CARD19 could interact with other death
domain family members that have been shown to localize to mitochondria in response to various
stimuli such as NLRP3 (Subramanian et al., 2013), ASC (Misawa et al., 2013), or caspase-2
(Lopez-Cruzan et al., 2016). Future investigations will examine whether CARD19 interacts with
other known death domain proteins that localize to mitochondria.
5.2.6.

Full length GSDMD/E appears to partially localize to the actin cortical network and
cell periphery following transient transfection of HEK293T or HeLa cells

Since Card19-/- BMDMs display only mild defects in cleaved gasdermin present in light
membrane fraction, we considered alternative methods to investigate whether CARD19 mediates
the stability or association of gasdermins with the plasma membrane. Our attempts to visualize
pore formation and stability in BMDMs by immunofluorescence were unsuccessful due to
technical limitations (data not shown). We therefore examined the localization of gasdermin D/E
following transient transfection in HEK293T cells, a system that has been used to reconstitute
multiple cell death pathways (Liu et al., 2016; Man et al., 2013; Oberst et al., 2010; Shi et al.,
2015a). Surprisingly, full-length gasdermin D partially localized to the cell periphery and
somewhat overlapped with actin (Figure 4.3, GSDMD CT-FLAG). Previously published
immunofluorescence revealed that full-length gasdermin D was cytoplasmic in HeLa cells (Liu et
al., 2016). To investigate whether cell types were responsible for the different localization
phenotypes, we subsequently found that full-length gasdermin D partially localized at the cell
periphery in HeLa cells (Figure 4.4, GSDMD CT-FLAG). We considered the possibility that
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endogenous caspases were cleaving transfected gasdermin D, resulting in liberation of the Cterminal FLAG. This was unlikely since we did not see overt signs of cell death following
transfection of full-length gasdermin D, which is consistent with previous reports that full-length
gasdermin does not induce cell death by itself (Kayagaki et al., 2015). Nevertheless, we obtained
the FLAG tagged C-terminus of gasdermin D (Kayagaki et al., 2015). In addition, our data
indicate that the C-terminus displayed partial nuclear localization in both HEK293T and HeLa
cells even though it does not contain a predicted nuclear localization sequence (Figure 4.7).
The gasdermin D constructs originally described by Lieberman and colleagues contained an
N-terminal FLAG tag (Liu et al., 2016), while the construct we obtained from Vishva Dixit utilized a
C-terminal tag (Kayagaki et al., 2015). Although gasdermin D does not have an identified
membrane targeting domain, N-terminal tags can interfere with proper membrane targeting. To
determine whether tags were responsible for differences in localization, we generated a Cterminal HA tag (GSDMD CT-HA) and removed the tag from the Lieberman gasdermin D
(Untagged GSDMD) (Figure 4.3). We found that gasdermin D constructs with a C-terminal tag or
no tag partially localized to the cell periphery in HEK293T and HeLa cells (Figure 4.3, 4.4).
When quantified, all four constructs partially co-stained with the actin cortical network. The
confocal microscopy images do not provide sufficient resolution to definitively conclude that
gasdermin D colocalizes or associates with either the actin network or the cell periphery.
Additional experiments that utilize super resolution microscopy, deconvolution analysis, or
electron microscopy would be required to sufficiently answer the question as to whether fulllength gasdermins might localize at or near the cell periphery. Furthermore, we will utilize bonafide plasma membrane and cytoplasmic markers that exclusively mark the cell periphery and
cytoplasm, respectively, to allow for accurate quantification and visualization of gasdermin D
localization after overexpression. Future experiments will additionally examine whether
destabilization of the cytoskeleton by actin and tubulin depolymerizing agents will disrupt
gasdermin D partial localization at the cell periphery. Although technical limitations have
prevented visualization of endogenous gasdermin D in primary BMDMs, our data is somewhat
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supported by our preliminary finding that full-length gasdermin D localizes to membrane fractions
in untreated BMDMs following biochemical fractionation (Figure 4.1B).
We investigated whether gasdermin D localization at the cell periphery was a general feature
of gasdermins by obtaining a C-terminal Myc and FLAG tagged gasdermin E construct.
Consistent with our gasdermin D localization data, our data indicate that gasdermin E partially
localizes at the cell periphery and co-stains with actin in HEK293T and HeLa cells (Figure 4.8).
Altogether, these results might offer a potential alternative explanation for gasdermin D/E
activation and suggest that in some cases, gasdermins may be associated with the plasma
membrane or cytoskeleton, poised for pore formation (Figure 4.6). Due to the numerous
limitations of transient expression systems discussed above, we do not know whether our
preliminary findings are biologically meaningful or reflect the true localization of endogenous
gasdermins in any primary cell type. Rigorous future investigations will be required to make any
conclusions regarding the generalizability of these findings.
5.3. Proposed Model and Unanswered Questions: CARD19 facilitates the transition from
initial GSDMD/E pore formation to terminal lysis
Altogether, the data in this study identifies CARD19 as a dual regulator of pyroptosis and
apoptosis downstream of caspase and gasdermin cleavage. Furthermore, we provide preliminary
evidence that CARD19 might promote the association of cleaved gasdermins with cellular
membranes. If conclusively validated in proposed future studies, these findings may identify
CARD19 as a regulator that modulates gasdermin activity subsequent to cleavage. Since the time
of initial pore formation as measured by PI uptake is similar between B6 and Card19-/- BMDMs
(Figure 2.5), we propose a potential model in which CARD19 may facilitate the progression to
terminal lysis following initial pore formation by gasdermin D and E (Figure 5.1). After initial pore
formation during pyroptosis, calcium influx initiates loss of mitochondrial membrane potential (de
Vasconcelos et al., 2019). As a mitochondrial resident, CARD19 could potentially mediate the
mitochondrial response to sudden changes in ion homeostasis and possibly promote insertion or
stabilization of additional gasdermin D and E pores to facilitate lysis (Figure 5.1 Question Mark
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1). Future experiments will investigate whether CARD19 modulates calcium flux and
mitochondrial membrane potential on a single cell level using an ImageExpress living-imaging
microscope.
Additionally, CARD19 could dynamically regulate ion flux or lipid composition at the plasma
membrane to promote the progression to terminal lysis (Figure 5.1 Question Mark 2). Plasma
membrane associated membranes or PAMS are highly dynamic sites of contact between the
plasma membrane, ER and mitochondrial membranes (Frieden et al., 2005; Lawrence and
Mandato, 2013) which are thought to be important for lipid homeostasis and ion regulation. The
mitochondrial porin protein voltage dependent anion-selective channel-1 (VDAC1) is also found at
the plasma membrane where it may be involved in iron uptake and sensing redox states within
the cell (Lawen et al., 2005). Bcl-2 family members interact with mitochondrial VDAC1 to induce
opening of the permeability transition pore and promote apoptosis (Shimizu et al., 2000a; Shimizu
et al., 2000b; Shimizu et al., 1999; Shimizu and Tsujimoto, 2000). It is possible that CARD19 may
interact with VDAC1 or modulate the mitochondrial or plasma membrane in some way to
functionally alter the state of mitochondrial and plasma membrane pores. Future studies will
examine whether CARD19 may interact with gasdermins or any of the known PAM proteins to
mediate cell death.
While we have identified a novel regulator of apoptosis and pyroptosis, our findings leave
many unanswered questions. Aside from identifying the mechanism by which CARD19 facilitates
terminal lysis, we do not know what additional factors determine this transition (Figure 5.1
Question Mark 3). We find far less cleaved gasdermin D during hyperactivation compared to
pyroptosis (Figure 2.14F, red box), suggesting that differing levels of gasdermin cleavage may
be a factor in the progression to lysis. However, the presence of cleaved gasdermin D in
hyperactivated lysates begs the question as to how hyperactivated gasdermin D pores refrain
from releasing LDH and lytic markers and where the cell crosses the point of no return.
The point of no return was previously thought to be terminal caspase cleavage, but numerous
studies have since dispelled this idea (Chen et al., 2014; Evavold et al., 2018; Gaidt et al., 2016;
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Gaidt and Hornung, 2017; Zanoni et al., 2016; Zanoni et al., 2017). While loss of membrane
integrity is an attractive terminal checkpoint, multiple repair pathways can be activated to prevent
lysis (Andrews et al., 2014; Blazek et al., 2015; Cheng et al., 2015; Corrotte et al., 2013; Tam et
al., 2010). Although there may not be a single unifying juncture for the diverse types of death
discussed here, catastrophic loss of mitochondrial membrane potential is a likely candidate (Tait
and Green, 2013). Single-cell based analysis that simultaneously examines viability and cytokine
production will be required to answer this question. Since we see no difference in gasdermin
cleavage in Card19-/- BMDMs, we know that there must be additional as-of-yet unidentified factors
that drive the transition from initial pore formation to lysis in a CARD19-dependent manner.
Another lingering question involves the relationship between hyperactivation, initial pore
formation, and terminal lysis (Figure 5.1 Question Mark 4). Our data suggest that
hyperactivation may be regulated by levels of gasdermin D cleavage, but it is unclear whether
hyperactivated cells will eventually progress to terminal lysis or if there is a true switch between
viable hyperactivation and cell death. CARD19 expression does not correlate with hyperactivation
or lysis; therefore CARD19-independent factors may exist that regulate the hyperactivation
checkpoint.
We additionally do not understand how initial gasdermin pores competent for IL-1 release
and PI uptake are able to exclude larger lytic markers such as HMGB1 and LDH (Figure 5.1
Question Mark 5). It may be that the initial pore is smaller, and that continued stimulation leads
to the formation of larger pores capable of inducing lysis. Alternatively, gasdermin pores might
undergo a conformational change after prolonged death inducing stimuli that allows for HMGB1
and LDH release. On the other hand, kinetics could be responsible for selective release of cellular
proteins such that protracted signaling allow for an increase in pores at the membrane.
Lastly, we do not know the mechanism by which CARD19 mediates anti-Yersinia host
defense (Figure 5.1 Question Mark 6). Since CARD19 is not required for production of IL-1 or
NFκB cytokines in vitro or in vivo, CARD19 may mediate protective cell death in vivo.
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Alternatively, loss of Card19 could impair the ability of key innate immune cell populations to
effectively kill Yp or restrict the replicative niche.
Our preliminary finding that full-length gasdermins may partially overlap with the cellperiphery and cortical actin network following transient transfection might provide a potential
alternative explanation by which gasdermins could be poised at membranes for cleavage and
pore formation. Although these data are strictly constrained by the limitations associated with
overexpression experiments and cell types utilized, they raise the possibility that CARD19 and
gasdermins might interact transiently at plasma membrane and mitochondrial interfaces or PAMs.
Since PAMs are thought to regulate ion homeostasis and phospholipid composition at the plasma
membrane, future experiments will investigate whether CARD19 facilitates insertion of gasdermin
pores by manipulating calcium flux or phosphoserine accumulation on the plasma membrane.

5.4. Concluding remarks
Regulated cell death is a highly conserved, fundamental mechanism by which the innate
immune system regulates homeostasis and development (Mori et al., 1995; Rodriguez et al.,
1997) and protects against infection and injury (Kajstura et al., 1996; Mariathasan et al., 2004;
Monack et al., 1997). Members of the death domain superfamily and CARD subfamily are
essential mediators of these pathways (Bouchier-Hayes and Martin, 2002). While many death
domain and CARD proteins have been identified and characterized in the context of RCD and
innate immunity, several more remain unstudied. As a whole, the data presented in this thesis
has identified a previously unappreciated role for one such CARD protein, CARD19 or BinCARD,
as a key regulator of caspase-dependent apoptosis and pyroptosis, downstream of caspase and
gasdermin cleavage and independent of IL-1 cytokine secretion.
While the RCD field has substantially expanded since the coining of apoptosis by Kerr and
colleagues in 1972, there is still much that we do not fully understand, particularly with regards to
the terminal steps of RCD pathways and the complexity of RCD cross-talk. As scientists, we often
take a reductionist perspective with genetic knockout and knock-in models to assess the impact

114

of a single regulator on RCD. These investigations have been extremely fruitful, but often fail to
account for the inherent redundancy of RCD pathways as evidenced by multiple pathway
activation in vivo during infection models. It is imperative that future studies investigate the
complexities of RCD pathway cross-talk, particularly during in vivo infection and injury models.
These studies will allow for a more authentic picture of what occurs outside of the petri dish and
may provide insight into the development of novel therapeutics or identify potential targets for
immunotherapy.

5.5. Figures
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Figure 5.1. CARD19 facilitates the transition from initial gasdermin D/E pore formation to
terminal lysis
Active caspases-1, -3, and -8 cleave gasdermin D and E during pyroptosis and apoptosis, leading
to initial pore formation that allows for mature IL-1 release and propidium iodide (PI) uptake.
CARD19 mediates the progression to terminal cell lysis following initial pore formation by
moderating calcium and ion homoeostasis, promoting the insertion of lysis-competent gasdermin
D/E pores, or through an unknown mechanism. Question Mark 1. Does CARD19 promote
terminal lysis by perturbing mitochondrial homeostasis or promoting loss of mitochondrial
integrity. Question Mark 2. Do CARD19 and gasdermins localize at or near PAMS? Question
Mark 3. What additional CARD19-independent factors are involved in the progression to terminal
lysis after pre-lytic pore formation. Question Mark 4. What is the relationship between initial
gasdermin pore formation, hyperactivation, and terminal lysis. Question Mark 5. Is there a
functional difference in the initial gasdermin pores competent for IL-1 release and PI uptake and
later pores that induce lysis? Question Mark 6. How does CARD19 mediate anti-Yersinia host
defense?
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CHAPTER 6: Methods and Materials
6.1. Experimental Model and Subject Details
6.1.1. Mice
C57BL/6 (B6) and Casp1/Casp11-/- mice were obtained from Jackson Laboratories and
subsequently maintained as a breeding line in-house. All previously published knockout mouse
lines used to generate BMDMs are indicated in Section 6.8. Ripk3-/- mice (Newton et al., 2004)
were a gift of Kim Newton and Vishva Dixit (Genentech). Ripk3/Casp8-/- mice (Oberst et al., 2011)
were a gift of Doug Green (St. Jude Children’s Hospital). Casp11-/- mice were originally generated
by Junying Yuan (Wang et al., 1998) and kindly provided by Tiffany Horng (Harvard University).
Breeders were routinely genotyped. Genotyping primers are listed in Section 6.7. Mice were
maintained in a specific pathogen-free facility by University Laboratory Animal Resources (ULAR)
staff in compliance with IACUC approved protocols.
6.1.2. Generation of Card19-/- mice
Card19-/- mice were produced by Lexicon Pharmaceuticals using a 129SvEvBrd ES cell line and
a targeting strategy resulting in replacement of exons 3-5 with a Bgeo-puro cassette. The
resulting CARD19 deletion removes amino acids 51-183, which includes the C-terminal half of the
CARD and the entire C-terminus, including the transmembrane domain. Mice were extensively
backcrossed to C57BL/6. Backcrossing was confirmed by SNP array mapping (Figure 2.9A).
6.1.3. Bone Marrow
Bone marrow derived macrophages were isolated and differentiated as previously described
(Brodsky et al., 2010). Briefly, isolated bone marrow cells from 6-10-week-old male and female
mice were grown at 37°C, 5% CO2 in 30% macrophage media (30% L929 fibroblast supernatant,
complete DMEM). BMDMs were harvested in cold PBS on day 7, and replated in 10%
macrophage media onto tissue culture (TC)-treated plates and glass coverslips in TC-treated
plates. Mavs-/- BMDMs were a gift from Carolina Lopez (University of Pennsylvania) purchased
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from Jackson Laboratories and backcrossed onto B6 to generate Mavs+/+ BMDMs. Gsdmd-/BMDMs were previously described (Rauch et al., 2017) and provided by Russell Vance.
6.1.4. Cell lines
HEK293T and HeLa cells (ATCC) were grown in complete DMEM and split every two-three days
with 0.05% trypsin-EDTA upon reaching approximately 80% confluency.
6.1.5. Bacteria
Bacteria strains used include Yersinia pseudotuberculosis (Yp) strain IP2666, Yp IP2666 ΔEJK
(lacking Yop effector proteins YopE, YopJ, and YopK), Yp strain 2777 (in vivo infections),
Salmonella enterica serovar Typhimurium strain SL1344, DH5α E. coli, and ΔoatA
Staphylococcus aureus. Bacterial strains were grown as previously described (Evavold et al.,
2018; Philip et al., 2014; Zwack et al., 2015). Briefly, bacteria were grown with aeration and
antibiotics at 28°C (Yersinia, irgasan) or 37°C (Salmonella, streptomycin, E. coli, none, S. aureus,
kanamycin). Yersinia strains were induced prior to infection by diluting the overnight culture 1:40
in 3 mL of inducing media (2xYT broth, 20 mM Sodium Oxalate, 20 mM MgCl2). Inducing culture
were grown at 28°C for 1 hour and shifted to 37°C for two hours with aeration. Salmonella strains
were induced prior to infection by diluting the overnight culture 1:40 in 3 mL inducing media (LB
broth, 300 mM NaCl), and grown without aeration for 3 hours at 37°C. Outgrowth cultures of
Shigella were grown from overnight cultures for 2 hours at 37°C with aeration. ΔoatA S. aureus
was grown overnight in Todd Hewitt Broth at 37°C with aeration (Evavold et al., 2018). Bacterial
growth was measured using OD600 on a spectrophotometer. Bacteria were pelleted, washed, and
resuspended in DMEM, serum-free media, or HBSS with 10% FBS for infection. In vitro infections
were performed at MOI 10 (Yp and S. Tm., fractionation and microscopy), MOI 20 (Yp, ΔEJK and
S. Tm., all other assays) or MOI 30 (E. coli, LDH) unless otherwise noted. ΔoatA infections were
performed at MOI 30 and 60. Thioglycolate in vitro infections were performed at MOI 10.
Gentamycin (100 mg/mL) was added one hour post infection. Inputs were plated on LB agar with
appropriate antibiotics to confirm MOI.
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6.1.6. Plasmids
All constructs are listed in Section 6.6. GSDMD CT-HA was generated by PCR mutagenesis and
confirmed by sequencing. Untagged GSDMD was generated by double digesting NT-FLAG
GSDMD and pcDNA3.1+ with NotI and BamHI and ligating the sticky ends together. Mutagenesis
primers are listed in Section 6.7. GSDMD constructs were previously described (Kayagaki et al.,
2015; Liu et al., 2016) and generously provided by Nobuhiko Kayagaki, Vishva Dixit (Genetech)
and Judy Lieberman (Addgene). Gasdermin E was obtained from Origene (MR218826).
Dimerizable caspase-8 and TEV constructs were graciously given by Andrew Oberst (Oberst et
al., 2010). All constructs were confirmed by sequencing prior to experimentation.

6.2. Method details
6.2.1. Cell viability assays
6.2.1.1. LDH release
Triplicate wells of BMDMs were seeded in TC-treated 96 well plates. BMDMs were infected with
indicated bacterial strains as indicated above. BMDMs were primed with 100 ng/mL LPS for 3
hours followed by 2.5 mM ATP treatment. BMDMs were treated with 10 uM staurosporine or 100
uM etoposide. BMDMs were pretreated with 100 uM zVAD(OMe)-FMK or 100 ug/mL
cycloheximide for 1 hour before treatment with 100 ng/mL LPS. For non-canonical inflammasome
cell death, BMDMs were primed with 400 ng/mL Pam3CSK4 for 3 hours and then infected with
DH5α E. coli, MOI 30 for 16-20 hours. 100 ug/mL gentamycin was added one hour post treatment
to all experimental conditions. At indicated time points, plates were spun down at 250g and
supernatants were harvested. Sups were combined with LDH substrate and buffer according to
the manufacturer’s instructions. Plates were read on a spectrophotometer at 490 nm. Percent
cytotoxicity was calculated by normalizing to maximal cell death (1% triton) and no cell death
(untreated cells).
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6.2.1.2. Propidium iodide (PI) uptake
Propidium iodide uptake was performed as previously described (Evavold et al., 2018). Briefly,
triplicate wells of BMDMs were seeded in TC-treated black-walled 96 well plates. BMDMs were
infected or treated as described above in 50 uL HBSS plus 10% FBS. Propidium Iodide (2x, 10
uM) was added in 50 uL HBSS to each well and incubated for 5 minutes in the dark to allow for
stabilization of the signal in the maximal cell death wells (1% triton). PI uptake was detected by
fluorescence on a BioTek Synergy HT Multi-Detection Microplate Reader (540/25 excitation,
590/35 emission, sensitivity 35, integration time 1 sec) every 2.5 minutes (S. Tm., ATP) or every
10 minutes (Yp, Sts) for the indicated time points. Gentamycin (100 ug/mL) was added one hour
post infection (Yp, Sts). Percent cytotoxicity was calculated as described for LDH.
6.2.1.3. Seahorse XF Cell Mito Stress Test
Seahorse XC Cell Mito Stress Test was performed according to the manufacturer’s instructions.
Briefly, sensor cartridges were calibrated overnight in Seahorse XF Calibrant. The XF Cell
Culture Microplate was coated with cell-tak adhesive in 0.1 M NaHCO3 for 30 minutes at room
temperature before being washed and sealed, 18 hours prior to plating. On the day of the assay,
BMDMs were untreated or primed with 100 ng/mL LPS for 3 hours. BMDMs were harvested in
cold PBS, counted and diluted in XF Base medium with 35mM glucose and 8 mM glutamine. Mito
Stress Test drugs were diluted in XF base medium to appropriate concentrations, oligomycin (1
uM), FCCP (1 uM), Rotenone/Actimycin A (0.5 uM). Triplicate wells of 2*106 BMDMs were plated
in Seahorse Media. XF cell culture microplate was run on an XFe96 Seahorse Analyzer (Agilant).
Oxygen consumption rate was measured at baseline, following injection of oligomycin, FCCP,
and rotenone/actimycin A, and after all three had been injected (Figure 2.10D, E).
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6.2.2. Microscopy
6.2.2.1. CARD19 and MitoTracker staining
BMDMs were seeded on round, glass coverslips and allowed to adhere overnight. BMDMs were
stained with 250 nM MitoTracker CMXRos in serum free media at 37°C, 5% CO2 for 30 minutes.
BMDMs were washed and infected with Yersinia pseudotuberculosis (MOI 10) for 2 hours at
37°C. BMDMs were fixed with 4% PFA, permeabilized with 0.2% Triton, and blocked in 10%
BSA. BMDMs were incubated with CARD19 (1:100) and MAVS (1:100) primary antibodies for 2
hours at 37°C, 5% CO2 in 4% BSA. BMDMs were washed in PBS and incubated with Alexa Fluor
rabbit 488 (1:5000) and Alexa Fluor mouse 514 (1:5000) at room temperature for 1 hour in 4%
BSA. BMDMs were washed in PBS and stained with Hoechst (1:2500) and Alexa Fluor 647
Phalloidin (1:50) for 30 min in PBS at RT. Coverslips were washed, mounted on glass slides with
Fluoromount-G, and dried overnight. Slides were imaged on a Leica SP5-II Confocal/FLIM
Microscope at 63x. Three z-stacks each containing 20-50 cells were taken for each genotype and
condition. Cells imaged for display were imaged at an additional 2.5x. The brightness and
contrast of display images were enhanced equally across genotypes using FIJI, with each
channel enhanced separately using secondary only, Card19-/- and Mavs-/- BMDMs, and unstained
controls. Images used for quantification were not altered. Z-stacks were quantified using Volocity.
Briefly, phalloidin (acin) staining was used to measure the total volume for each cell. The volume
of CARD19, MAVS, and/or MitoTracker CMXRos staining above negative controls was
compartmentalized into cell boundaries delineated by actin. Percent overlap was calculated by
dividing the total amount of overlap by the total amount of staining (i.e. volume of CARD19
overlap with MitoTracker / total CARD19 volume in the cell). Thresholds for positive staining
signal were set using Card19-/- and Mavs-/- BMDMs for CARD19 and MAVS staining, respectively
as well as secondary-only and unstained controls for Phalloidin and Hoechst. 50-200 cells were
analyzed per genotype and condition.
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6.2.2.2. HMGB1 release
BMDMs were seeded as described above, treated with staurosporine for indicated time points,
fixed, permeabilized, and blocked. BMDMs were stained for HMGB1 (1:200) at 37°C for 1 hour,
Alexa Fluor rabbit 488 (1:5000) at RT for 1 hour, and Hoechst and Phalloidin at RT for 30 min.
Slides were imaged as described above, with a single z-plane taken per field. Percent nuclear
HMGB1 was quantified by identifying total HMGB1 staining per cell and comparing the overlap
with nuclear staining (Hoechst) in Volocity. 65-200 cells were analyzed per genotype, condition,
and time point. Cloud analysis was completed by counting the number of HMGB1 clouds per field
of view with 5-8 fields per condition.
6.2.2.3. Deconvolution
BDMDs were seeded and stained as described above. Slides were imaged using a 63x objective
at an additional 5x magnification (pixel size ~50 nm). Z-stacks were acquired with a 0.08 μm step
size. All images were deconvolved with Huygens Professional version 18 (Scientific Volume
Imaging, The Netherlands, http://svi.nl), using the CMLE algorithm, with SNR:25 and 40
iterations.
6.2.3. Western blotting
BMDMs were seeded in TC-treated 24 or 12 well plates. Necrostatin (60 uM, Nec-1), DEVD-fmk
(100 uM), and IETD-fmk (500 uM) were used to inhibit RIPK1, caspase-3/-7, and caspase-8,
respectively, for 1 hour prior to stimulation. Following infection or treatment in serum-free media,
supernatants were removed and TCA precipitated. Briefly, supernatants were spun down to
remove cell debris and TCA precipitated overnight at 4°C. Sups were spun down and washed
with acetone. Remaining TCA was neutralized with Tris, and the pellet was resuspended in 5x
sample buffer (125 mM Tris, 10% SDS, 50% glycerol, 0.06% bromophenol blue, 1% βmercaptoethanol). BMDMs were lysed in lysis buffer (20 mM HEPES, 150 mM NaCl, 10%
glycerol, 1% Triton X-100, 1mM EDTA, pH7.5) plus 1x complete protease inhibitor cocktail
(Roche) and 1x sample buffer (25 mM Tris, 2% SDS, 10% glycerol, 0.012% bromophenol blue,
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0.2% β-mercaptoethanol). Lysates and supernatants were boiled, centrifuged at full speed for 5
minutes or briefly, respectively, and run on 4-12% gradient polyacrylamide gels and transferred to
PVDF. Membranes were immunoblotted using the following primary antibodies: β-Actin (1:5000),
Bid (1:500), CARD19 (1:500), Caspase 1 (1:360), Caspase 3 (1:1000), Caspase 8 (1:1000),
GSDMD (1:500), HMGB1 (1:1000), MAVS (1:500), and PARP (1:1000). Species specific HRPconjugated secondary antibodies were used for each antibody (1:5000). Membranes were
developed using Pierce ECL Plus and SuperSignal West Femto Maximum Sensitivity Substrate
according to the manufacturer’s instructions. Western blot time-courses were performed in
parallel with cytotoxicity assays to accurately interpret protein release before and after overt cell
death.
6.2.4. Mitochondrial fractionation
The biochemical fractionation scheme is outlined in Figure 2.4B. In brief, 10-15 million BMDMs
were untreated, infected with Yersinia pseudotuberculosis for 2-3 hours, MOI 10, or treated with
10 uM Staurosporine for 2-3 hours. BMDMs were harvested in PBS, washed 1x in PBS,
resuspended in Resuspension Buffer (RSB - 10 mM NaCl, 1.5 mM CaCl2, 10 mM Tris-HCl, pH
7.5, 1x complete Protease Inhibitor Cocktail, 100 uM PMSF, 25 mM NaF, 1 mM DTT) and
incubated on ice for 30 min. Cells were disrupted with a motorized Potter-Elvehjem homogenizer
at 4000 rpm until 65-75% of the cells were lysed. Mitochondrial Extraction Buffer (MEB - 20 mM
mannitol, 70 mM sucrose, 5 mM Tris-HCl, 5 mM EDTA, pH 7.5 plus protease and phosphatase
inhibitors) was added and spun at 950g twice to remove the nucleus. The supernatant (S0.95b)
was removed and spun at 10,000g to pellet mitochondria. The supernatant (S10) was removed
as the cytosolic fraction and the pellet (P10a) was washed twice with MEB. The final
mitochondrial pellet (S10b) was resuspended in MEB. The nuclear pellet (P0.95) was
resuspended four times in Nuclear Wash Buffer (NWB - 10 mM HEPES, 10 mM KCl, 0.1 mM
EDTA, pH 7.9 plus protease and phosphatase inhibitors) and spun down at 8,5000 RPM. P8.5
was resuspended in Nuclear Extraction Buffer (NEB - 20 mM HEPES, 0.4 mM NaCl, 1 mM
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EDTA, pH 7.9 plus protease and phosphatase inhibitors). The nuclear fractions were shaken at
4°C on a vortex and then spun down at full speed (~15,000g). The supernatant (S15) was
recovered as the nuclear fraction. Fractions were normalized using the BCA assay, run on SDSPAGE gels, transferred to PVDF membranes and probed for CARD19, GSDMD, Bax, Bak,
MAVS, Calnexin (1:500), Na+/K+ ATPase (1:2000), Tubulin (1:2500, cytoplasmic control), COX IV
(1:500, mitochondrial control), and HDAC1 (1:1000, nuclear control). All spins were conducted at
4°C. All buffers contained protease and phosphatase inhibitors.
6.2.5. Membrane fractionation
Total cell membrane fractions were generated using the plasma membrane protein extraction kit
(Abcam, ab65400) according to the manufacturer’s instructions with minor modifications and
diagramed in Figure 4.2E. In brief, 50-65 million BMDMs were harvested in PBS per condition.
Cells were washed in PBS and resuspended in Homogenize Buffer Mix with protease inhibitors.
Cells were disrupted with a motorized Potter-Elvehjem homogenizer as described in Section
6.2.4. Cells were spun down to remove the nuclear fraction and debris. Subsequently cells were
spun down to separate the cytosol and total membrane fractions. The light membrane fraction
was extracted by resuspending the total membrane fraction in upper and lower phase solution
and spinning down. The upper phase containing the light membrane fraction was extracted using
lower phase solution. The upper phase was mixed with water, and the light membrane fraction
was pelleted by spinning at full speed for 1 hour. The supernatant was added to the previously
generated lower fraction and the organelle membrane fraction was pelleted by spinning at full
speed for 1 hour. The pellets were resuspended in Mitochondrial Extraction Buffer. Membrane
and cytosolic fractions were normalized to 1 mg/mL using a Nanodrop. All spins were conducted
at 4°C. Fractions were boiled, run on SDS-PAGE gels, transferred to PVDF membranes and
probed GSDMD, GSDME, CARD19, tubulin (cytosol control), and COX IV (total membrane
control). Unboiled fractions were probed for Na+/K+ ATPase (light membrane control).
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6.2.6. Cytokine release
Triplicate wells of BMDMs were seeded in TC-treated 48 well plates. All conditions except
untreated were primed with 100 ng/mL LPS for 3-4 hrs. BMDMs were infected with bacterial
strains as indicated or treated with 2.5 mM ATP. ELISA supernatants were added to IL-1α, IL-1β,
IL-6, IL-12, and TNF-α capture antibody-coated 96-well plates and incubated at 4°C overnight.
Plates were incubated with the appropriate biotinylated antibodies in 1% BSA, followed by
streptavidin. ELISAs were developed with o-phenylenediamine dihydrochloride in citric acid buffer
and stopped with 3M sulfuric acid. Plates were detected on a spectrophotometer at 490 nm.
6.2.7. Hyperactivation
Triplicate wells of BMDMs were seeded in TC-treated 48 well plates (ELISA, LDH), and 12 well
plates (western). All conditions except untreated were primed with 1 ug/mL LPS for 4 hrs.
BMDMs were infected with S. Tm. (MOI 20) or ΔoatA S. aureus (MOI 30 or 60) as described
above. Gentamycin (100 ug/mL) was added 1 hr post infection. Sups and lysates were harvested
at 30 min (S. Tm.) or 2 and 6 hrs (ΔoatA) and analyzed by ELISA for IL-1B release, by LDH for
cytotoxicity, or by western blotting for caspase-1, GSDMD, CARD19, and actin (loading control).
6.2.8. HEK293T cell transfections
6.2.8.1. Caspase-8 and gasdermin D co-transfection
3x105 293T cells were seeded in 24 well plates. 293T cells were transfected with a 2:1:1 ratio of
caspase-8 (100 ng): GSDMD (50 ng): TEV protease (50 ng) with Lipofectamine 2000 in optimum
and low serum DMEM (2% FBS) according to the manufacturer’s instructions. 24 hours post
transfection, media was replaced with SFM, and 1 uM AP20187 (dimerizer) was added. PI (5 uM)
was added to wells for PI imaging. Brightfield images were acquired on an inverted Nikon Eclipse
TE2000-U at 20x magnification. Sups and lysates were harvested for western blotting six hours
post-dimerizer.
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6.2.8.2. Microscopy
3x105 293T cells were seeded on coverslips in 24 well plates. 293T cells were transfected with
GSDMD CT-FLAG, GSDMD CT-HA, NT-FLAG GSDMD, Untagged GSDMD, CT GSDMD CTFLAG, CT NT-FLAG GSDMD, or GSDME-FLAG. 24 hours post-transfection cells were stained
with MitoTracker CMXRos, fixed, permeabilized, and blocked as described in Section 6.2.2.1.
Cells were incubated with HA (1:500) and FLAG (1:500) primary antibodies, stained for actin and
DNA, and mounted on slides. Cells were imaged as described in Section 6.2.2.1.
6.2.9. Thioglycolate injections
Age and sex-matched B6 and Card19-/- mice between 9-11 weeks were injected intraperitoneally
with 4% aged thioglycolate or PBS. 48 hours after injection, mice were euthanized using CO2 in
accordance with approved IACUC protocols. Peritoneal exudate cells were harvested with a 10
mL cold PBS lavage. RBCs were lysed using RBC lysis buffer (155 mM NH4Cl, 12 mM NaHCO3,
0.1 mM EDTA). PECS were counted using trypan blue exclusion on a hemocytometer and
seeded in triplicate technical replicates per mouse in complete DMEM without antibiotics in 96
well plates (1*105 cells for PBS PECS, 0.7*105 cells for TG PECS). PBS PECS were pooled prior
to plating. Cells were washed with warm PBS to remove non-adherent cells and infected with Yp,
S. Tm. or treated with staurosporine as described above.
6.2.10. Mouse infections
Age and sex-matched B6 and Card19-/- mice between 8-12 weeks were orally infected with 108
CFU of Yersinia pseudotuberculosis strain IP2777 after 16 hours of fasting. Mice were monitored
for survival for 30 days or were euthanized using CO2 followed by cervical dislocation, in
compliance with IACUC approved euthanasia protocols. Blood was harvested by cardiac
puncture following death. Serum cytokine levels (IL-6, IL-12, TNF-α) were measured by ELISAs
as described above. Spleen, liver, mesenteric lymph nodes, and Peyer’s patches were removed,
weighed, homogenized, diluted in PBS, and plated on LB agar plates with irgasan for CFUs.
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6.2. Statistical analysis
Statistical analysis was completed using GraphPad Prism v.5. Two-tailed Student’s t test or
paired Student’s t test were used for comparisons of two groups. One-way analysis of variance
(ANOVA) with pairwise comparisons and Bonferroni post-test correction was used for multiple
group comparisons. Repeated-measures ANOVA or paired t tests were used for matched
samples. Unless indicated otherwise, mean ± S.E.M. is graphed. Studies were conducted without
blinding or randomization. Values of p < 0.05 were considered statistically significant.
6.3. Data and software
Volocity 6.3 (PerkinElmer) was used for microscopy quantification. Deconvolution analysis was
conducted using Huygens Professional (Science Volume Imaging). FIJI was used to adjust
brightness and contrast of images for display purposes. Prism v5.0 (GraphPad) was used for
graphing and statistical analysis.

6.4. Lists of reagents
6.4.1. List of antibodies, cytokines, and reagents

Reagent
Antibodies
Anti-mouse β-actin (clone AC-74)

Source

Identifier

Sigma-Aldrich

Anti-mouse bax (clone E63)

Abcam

Anti-mouse bak

Cell Signaling Technologies

Anti-mouse bid

R&D

Anti-mouse calnexin

Abcam

Anti-human CARD19

Atlas Antibodies

Anti-mouse caspase-1
Anti-mouse caspase-3

Genetech
Cell Signaling Technologies

Cat# A2228,
RRID:AB_476697
Cat# ab32503,
RRID:AB_725631
Cat# 3814S,
RRID:AB_2290287
Cat# MAB860,
RRID:AB_2063462
Cat# ab22595,
RRID:AB_2069006
Cat# HPA010990,
RRID:AB_2668400
N/A
Cat# 9662S,
RRID:AB_10694681
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Anti-mouse caspase-8 (clone 1G12)

Enzo Life Technologies

Anti-human caspase-8 (clone C15)
Anti-mouse COX IV

Adipogen
Abcam

Anti-mouse cytochrome c

Cell Signaling Technologies

Anti-mouse DFNA5/GSDME (clone
EPR19859)
Anti-mouse FLAG (clone M2)
Anti-mouse GSDMD (clone EPR19828)
Anti-mouse HDAC1

Abcam

Anti-rabbit HA (clone C29F4)
Anti-mouse HMGB1

Cell Signaling Technologies
Abcam

Anti-mouse KDEL

Abcam

Anti-mouse MAVS (clone C-1)

Santa Cruz

Anti-mouse PARP
Anti-mouse sodium/potassium ATPase
(clone EP1845Y)
Anti-mouse α-tubulin

Cell Signaling Technology
Abcam

Anti-mouse V5-HRP Conjugate

Invitrogen

Anti-rabbit IgG AF488

Molecular Probes

Anti-mouse IgG AF488

Thermo Fisher Scientific

Anti-mouse IgG AF514

Thermo Fisher Scientific

Anti-rabbit IgG AF532

Thermo Fisher Scientific

Anti-mouse IgG AF546

Thermo Fisher Scientific

Anti-rabbit IgG AF546

Thermo Fisher Scientific

Anti-mouse IgG, HRP

Cell Signaling Technologies

Anti-Rat IgG HRP

Jackson Labs

Anti-Rabbit IgG HRP

Jackson Labs

Anti-mouse IL-1α (clone ALF-161)

BD Biosciences

Anti-mouse IL-1α biotin

BioLegend

Anti-mouse IL-1β

Thermo Fisher Scientific

Sigma Aldrich
Abcam
Cell Signaling Technologies

Sigma-Aldrich
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Cat# ALX-804-447C100,
RRID:AB_2050952
Cat# AG-20B-0057
Cat# ab33985,
RRID:AB_2085427
Cat# 4272S,
RRID:AB_10694552
Cat# ab215191,
RRID:AB_2737000
Cat# F1804
Cat# ab209845
Cat# 2062,
RRID:AB_2118523
Cat# 3724T
Cat# ab18256,
RRID:AB_444360
Cat# ab12223,
RRID:AB_298945
Cat# sc-365333,
RRID:AB_10844335
Cat# 9542T
Cat# ab76020,
RRID:AB_1310695
Cat# T5168,
RRID:AB_477579
Cat# R96125,
RRID:AB_159316
Cat# A-11008,
RRID:AB_143165
Cat# A-11001,
RRID: AB_2534069
Cat# A-31555,
RRID:AB_2536171
Cat# A-11009,
RRID:AB_2534076
Cat# A-11003,
RRID:AB_141370
Cat# A-11010,
AB_2534077
Cat# 7076,
RRID:AB_330924
Cat# 112-035-143,
RRID:AB_2338138
Cat# 111-035-144,
RRID:AB_2307391
Cat# 550604,
RRID:AB_393776
Cat# 512504,
RRID:AB_2124220
Cat# 14-7012-85,
RRID:AB_468397

Anti-mouse IL-1β biotin

Thermo Fisher Scientific

Anti-mouse IL-6 (clone MP5-20F3)

BD Biosciences

Anti-mouse IL-6 biotin (clone MP5-32C11)

BD Biosciences

Anti-mouse IL-12 (p40 / p70) (clone
C15.6)
Anti-mouse IL-12 (p40 / p70) biotin (clone
C17.8)
Anti-mouse TNF

BD Biosciences

Anti-mouse TNF biotin (clone MP6-XT22)

BioLegend

Anti-mouse IFN-γ (clone AN-18)

Thermo Fisher Scientific

Anti-mouse IFN-γ biotin (clone R4-6A2)

Thermo Fisher Scientific

Dyes and Microscopy Reagents
16% Paraformaldehyde Aqueous
Solution, EM Grade
Hoechst
Fluormount G
MitoTracker CMXRos
Phalloidin AF647
Propidium iodide
Chemicals and Recombinant Proteins
Adenosine 5ʹ-Triphosphate, Disodium Salt
AP20187 (dimerizer)
Cycloheximide
z-DEVD(OMe)-FMK
Etoposide
Gentamicin Sulfate
Glycine
z-IETD(OMe)-FMK
Irgasan
Lipopolysaccharide from E coli
Pam3CSK4
Protease Inhibitor Cocktail: complete,
mini, EDTA-Free
Recombinant Mouse IFN-γ
Recombinant Mouse IL-1α
Recombinant Mouse IL-1β
Recombinant Mouse IL-6
Recombinant Mouse IL-12
Recombinant Mouse TNF-α
Staurosporine from Streptomyces sp.
Streptamycin Sulfate

BD Biosciences
BioLegend

Cat# 13-7112-85,
RRID:AB_466925
Cat# 554400,
RRID:AB_398549
Cat# 554402,
RRID:AB_395368
Cat# 551219,
RRID:AB_394097
Cat# 554476,
RRID:AB_395419
Cat# 506309,
RRID:AB_315430
Cat# 506311,
RRID:AB_315342
Cat# 14-7313-85,
RRID:AB_468472
Cat# 13-7312-85,
RRID:AB_466939

Electron Microscopy Services

Cat# 15710

Thermo Fisher Scientific
Thermo Fisher Scientific
Life Technologies
Thermo Fisher Scientific
Thermo Fisher Scientific

Cat# 62249
Cat# 00-4958-02
Cat# M7512
Cat# A22287,
RRID:AB_2620155
Cat# P3566

Millipore
ApexBio
Sigma-Aldrich
SM Biochemicals
Sigma-Aldrich
Sigma-Aldrich
Sigma-Aldrich
SM Biochemicals
Sigma-Aldrich
Sigma-Aldrich
Invivogen
Roche

Cat# 1191
Cat# B1274
Cat# C7698
Cat# SMFMK003
Cat# E1383
Cat# G1914
Cat# 8898
Cat# SMFMK004
Cat# 72779
Cat# L2880
Cat# tlrl-pms
Cat# 11836170001

eBioscience
R&D
R&D
R&D
R&D
BioLegend
Sigma-Aldrich
Gold Technologies

Cat# 485-MI-100
Cat# 400-ML-005
Cat# 14-8012-80
Cat# 406-ML-005
Cat# 419-ML-010
Cat# 575206
Cat# S5921
Cat# G-400-1
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Streptavidin HRP
zVAD(Ome)-FMK
Lipofectamine 2000
Thioglycolate
Todd Hewitt Broth for microbiology
Commercial Assays
Caspase-Glo 8 Assay
CellTiter Glo Luminescent Cell Viability
Assay
ECL Western Blotting Substrate
LDH Cytotoxicity Detection Kit
Plasma Membrane Protein Extraction Kit
Plasmid Maxiprep Kit
Seahorse XF Cell Mito Stress Test Kit
SuperSignal West Femto Maximum
Sensitivity Substrate

BD Biosciences
SM Biochemicals
Invitrogen
Sigma-Aldrich
Sigma-Aldrich

Cat# 554066
Cat# SMFMK001
Cat# 11668027
Cat# 1167610500
Cat# T1438

Fisher Scientific
Promega

Cat# PRG8201
Cat# G7571

Thermo Fisher Scientific
Takara Bio
Abcam
Qiagen
Agilant
Thermo Fisher Scientific

Cat# 32106
Cat# MK401
Cat# ab65400
Cat# 12162
Cat# 103015-100
Cat# 34095

6.4.2. List of recombinant DNA
Recombinant DNA
pcDNA3.1+
pcDNA3.1+/FL GSDMD-FLAG (GSDMD CT-FLAG)
pcDNA3.1+/FL GSDMD-HA (GSDMD CT-HA)
pcDNA3.1+/C-term GSDMD (277-476)-FLAG (CT
GSDMD CT FLAG)
pFLAG-CMV-4/FL-GSDMD (NT FLAG GSDMD)

Igor Brodsky
Vishva Dixit
This paper
Vishva Dixit

pCMV-6/GSDME CT-Myc FLAG

Judy
Lieberman
This paper
Judy
Lieberman
Origene

pBabe/FBKP-Wt Caspase-8-T2A-GFP-T2A-Puro

Andrew Oberst

pBabe/FBKP-Casp8 Catalytic Mutant-T2A-GFP-T2APuro
pBabe/FBKP-Casp8 D5A Uncleavable-T2A-GFP-T2APuro
pBabe/FBKP-Casp8-TEV-T2A-GFP-T2A-Puro

Andrew Oberst

pcDNA3.1/TEV-V5

Andrew Oberst

pcDNA3.1+/FL-GSDMD No tag (untagged GSDMD)
pFLAG-CMV-4/CT-GSDMD (CT NT-FLAG GSDMD)

6.4.3. List of primers
Oligonucleotides
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Andrew Oberst
Andrew Oberst

(Kayagaki et al.,
2015)
(Kayagaki et al.,
2015)
Addgene# 80950
Addgene# 80953
Origene#
MR218826
(Oberst et al.,
2010)
(Oberst et al.,
2010)
(Oberst et al.,
2010)
(Oberst et al.,
2010)
(Oberst et al.,
2010)

CARD19 Wt genotyping primers, (297 bp)
CATGGATGTACAGAGCTCGGTAA,
CGTTGCCCTGGAGACACAGTATT
CARD19 Knockout genotyping primers (281 bp)
CGGAATTGATCCCGCTCGAA,
CGTTGCCCTGGAGACACAGTATT

IDT

This paper

IDT

This paper

6.4.4. List of experimental models
Cell Lines
HEK 293T Cells
HeLa Cells
Mice
129S1/SvlmJ (129/Sv)
C57BL/6J Mice (B6)
Card19-/- & Card19+/- Mice
Casp1/Casp11-/- Mice
Ripk3/Casp8-/- Mice
Ripk3-/- Mice
Bone Marrow
Casp11-/- Bone Marrow
Gsdmd-/- Bone Marrow
Mavs-/- & Mavs+/+ Bone Marrow

ATCC
ATCC

Bacterial Strains
E. coli DH5α
ΔoatA Staphylococcus aureus
Salmonella Typhimurium SL1344
Yersinia pseudotuberculosis IP2777
Yersinia pseudotuberculosis IP2666
Yersinia pseudotuberculosis IP2666
ΔyopEJK

Jackson Labs
Jackson Labs
This paper
Jackson Labs
Doug Green
Kim Newton, Vishva Dixit

Cat# 002448
Cat# 000664

Junying Yuan
Russell Vance
Carolina Lopez, Jackson
Labs

(Wang et al., 1998)
(Rauch et al., 2017)
Cat# 008634

N/A
Jonathan Kagan
(Hoiseth and Stocker,
1981)
Stanley Falkow
Jim Bliska
Erin Zwack, Igor Brodksy

Cat# 016621
(Oberst et al., 2011)
(Newton et al., 2004)

(Evavold et al., 2018)
(Simonet and Falkow,
1992)
(Hersh et al., 1999)
(Zwack et al., 2015)

6.4.5. Software and Algorithms
Software and Algorithms
FIJI
Volocity 6.3
Huygens Professional version
18.04
Prism 5.0

(Schindelin et al., 2012)
PerkinElmer
Scientific Volume Imaging
GraphPad
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https://imagej.net/Fiji/Downloads
http://cellularimaging.perkinelmer.
com/downloads/detail.php?id=14
http://svi.nl
https://www.graphpad.com/scienti
fic-software/prism/
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